Review Article  Open Access


World J Mens Health. 2020 Oct;38(4):412-471. English.
Published online Aug 06, 2020.  https://doi.org/10.5534/wjmh.200128
Copyright © 2020 Korean Society for Sexual Medicine and Andrology
Sperm DNA Fragmentation: A New Guideline for Clinicians
Ashok Agarwal,1 Ahmad Majzoub,2,3 Saradha Baskaran,1 Manesh Kumar Panner Selvam,1 Chak Lam Cho,4,5 Ralf Henkel,6,7 Renata Finelli,1 Kristian Leisegang,8 Pallav Sengupta,9 Catalina Barbarosie,10 Neel Parekh,11 Marco G. Alves,12 Edmund Ko,13 Mohamed Arafa,2,14 Nicholas Tadros,15 Ranjith Ramasamy,16 Parviz Kavoussi,17 Rafael Ambar,18 Manish Kuchakulla,16 Kathy Amy Robert,1 Concetta Iovine,19 Damayanthi Durairajanayagam,20 Sunil Jindal,21 and Rupin Shah22
1American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH, USA.
2Department of Urology, Hamad Medical Corporation, Doha, Qatar.
3Department of Urology, Weill Cornell Medicine - Qatar, Doha, Qatar.
4Department of Surgery, Union Hospital, Hong Kong.
5S. H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong.
6Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
7Department of Medical Bioscience, University of the Western Cape, Bellville, South Africa.
8School of Natural Medicine, Faculty of Community and Health Sciences, University of the Western Cape, Bellville, South Africa.
9Department of Physiology, Faculty of Medicine, Bioscience and Nursing, MAHSA University, Jenjarom, Malaysia.
10Department of Genetics, Faculty of Biology, University of Bucharest, Bucharest, Romania.
11Department of Urology, Cleveland Clinic Foundation, Cleveland, OH, USA.
12Department of Microscopy, Laboratory of Cell Biology & Unit for Multidisciplinary Research in Biomedicine (UMIB), Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal.
13Department of Urology, Loma Linda University, Loma Linda, CA, USA.
14Andrology Department, Cairo University, Giza, Egypt.
15Division of Urology, Southern Illinois University School of Medicine, Springfield, IL, USA.
16Department of Urology, University of Miami, Miami, FL, USA.
17Austin Fertility & Reproductive Medicine/Westlake IVF, Austin, TX, USA.
18Urology Department of Centro Universitario em Saude do ABC, Santo André, Brazil.
19Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania “Luigi Vanvitelli”, Caserta, Italy.
20Department of Physiology, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Malaysia.
21Department of Andrology and Reproductive Medicine, Jindal Hospital, Meerut, India.
22Department of Urology, Lilavati Hospital and Research Centre, Mumbai, India.

Correspondence to: Ashok Agarwal. Andrology Center and American Center for Reproductive Medicine, Cleveland Clinic, Mail Code X-11, 10681 Carnegie Avenue, Cleveland, OH 44195, USA. Tel: +1-216-444-9485, Fax: +1-216-445-6049, Email: agarwaa@ccf.org , Website: www.Clevelandclinic.org/ReproductiveResearchCenter
Received July 11, 2020; Revised July 13, 2020; Accepted July 13, 2020.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.




Abstract

Sperm DNA integrity is crucial for fertilization and development of healthy offspring. The spermatozoon undergoes extensive molecular remodeling of its nucleus during later phases of spermatogenesis, which imparts compaction and protects the genetic content. Testicular (defective maturation and abortive apoptosis) and post-testicular (oxidative stress) mechanisms are implicated in the etiology of sperm DNA fragmentation (SDF), which affects both natural and assisted reproduction. Several clinical and environmental factors are known to negatively impact sperm DNA integrity. An increasing number of reports emphasizes the direct relationship between sperm DNA damage and male infertility. Currently, several assays are available to assess sperm DNA damage, however, routine assessment of SDF in clinical practice is not recommended by professional organizations. This article provides an overview of SDF types, origin and comparative analysis of various SDF assays while primarily focusing on the clinical indications of SDF testing. Importantly, we report four clinical cases where SDF testing had played a significant role in improving fertility outcome. In light of these clinical case reports and recent scientific evidence, this review provides expert recommendations on SDF testing and examines the advantages and drawbacks of the clinical utility of SDF testing using Strength-Weaknesses-Opportunities-Threats (SWOT) analysis.

Keywords:
Assisted reproductive techniques outcome; Clinical guidelines; Infertility, male; Oxidative stress; Sperm DNA fragmentation
INTRODUCTION

Infertility is defined as the failure of a couple to achieve a clinical pregnancy after one year of regular, unprotected sexual intercourse [1]. Infertility affects more than 15% of couples globally with male factors alone or in combination with female factors, contributing to 50% of the cases [2]. Evaluation of infertile men still relies on conventional semen analysis, though it alone does not accurately predict male fertility potential and success of assisted reproductive technology (ART) [3]. In fact, about 15% of infertile patients have a normal semen analysis [4]. However, assessment of sperm concentration, motility and morphology may not fully reflect impaired sperm DNA integrity [5], which is detrimental for normal fertilization, embryo development and success of ART [6].

Sperm DNA fragmentation (SDF) can be caused by extrinsic factors (i.e., heat exposure, smoking, environmental pollutants, and chemotherapeutics) as well as intrinsic factors (i.e., defective germ cell maturation, abortive apoptosis, and oxidative stress [OS]) [7]. Compelling evidence demonstrates that OS is a major contributor to male infertility [8]. Reactive oxygen species (ROS) are vital for physiological processes such as apoptosis and capacitation, but an overproduction leads to various deleterious consequences including SDF [9]. Types of DNA damage include mismatch of bases, loss of base (abasic site), base modifications, DNA adducts and crosslink, pyrimidine dimers and single strand breaks (SSB) and double strand breaks (DSB) (Fig. 1). Any of these alterations can induce SDF and compromise natural conception or ART outcomes.


Fig. 1
Different types of DNA damage that can occur at DNA level: mismatched bases, abasic sites, base modifications (oxidation, alkylation, deamination), adducts and intrastrand crosslinks, pyrimidine dimers, and single and double strand fragmentation. ROS: reactive oxygen species, UV: ultraviolet.
Click for larger imageDownload as PowerPoint slide

Since 1999, there has been a significant increase in the number of studies reporting an association between SDF and male infertility. According to a recent scientometric analysis, the primary focus of SDF research in the past 20 years has emphasized lifestyle factors, varicocele, and asthenozoospermia [10]. Increased SDF levels have been implicated in male infertility while being associated with conditions such as varicocele, male accessory gland infection, advanced paternal age, cancer, chronic illness, exposure to environmental toxins and lifestyle factors [11].

Moreover, numerous studies have found that increased SDF adversely impacts conception rates [12, 13, 14]. Evidence shows that DNA damage in spermatozoa can affect the health and well-being of offspring [15]. Consequently, the negative impact of SDF on the male fertility potential may encourage more clinicians to utilize SDF testing in the clinical setting [16]. Interventions have also been explored to improve fertility outcomes and promote healthy offspring.

The present article aims to highlight the clinical utility of SDF testing by providing current evidence for its use in the management of the infertile male. This review begins by examining the underlying mechanisms and risk factors of SDF. It then describes the clinical tests associated with different types of DNA fragmentation, followed by the clinical indications for SDF testing. Finally, male infertility case scenarios with high SDF are presented along with expert recommendations on its management and an illustration of strengths, weaknesses, opportunities and threats (SWOT) of SDF testing.

ORIGIN OF SPERM DNA FRAGMENTATION

1. Primary mechanisms underlying sperm DNA fragmentation

SDF is primarily induced by defective maturation and abortive apoptosis occurring within the testis, or by OS throughout the male reproductive tract [17]. During spermatogenesis, chromatin is compacted through histone exchange with transitional proteins and protamines [18]. This is facilitated by the endogenous nuclease topoisomerase II, creating DNA breaks to reduce torsional stress for histone disassembly and chromatin packaging [19, 20, 21]. If these breaks are not repaired, impairment of chromatin packaging may result in defective maturation and the appearance of sperm with increased SDF in the ejaculate [22, 23, 24, 25, 26, 27]. SDF can also be induced by abortive apoptosis during spermatogenesis. Apoptosis ensures that no defective germ cells differentiate into spermatozoa, however failure of this process may result in the accumulation of spermatozoa expressing apoptotic markers in the ejaculated semen (Fig. 2) [28, 29, 30]. Extrinsic apoptosis is mediated through Fas-ligand binding to a death receptors, such as Fas, activating caspase-8 or 10 [31]. Indeed, the expression of Fas in the ejaculated sperm is an indicator of increased abortive apoptosis [32]. Excessive ROS can induce DNA damage [33] and also activate apoptotic pathways in spermatozoa [34]. Moreover, SDF can be indirectly induced by OS through by-products of lipid peroxidation, particularly malondialdehyde (MDA) and 4-hydroxynonenal (4HNE) which can introduce DNA adducts, such as 8-hydroxy-2′-deoxyguanosine (8-OHdG), 1,N6-ethenoadenosine, and 1,N6-ethenoguanosine, resulting in DNA damage [33, 35, 36, 37]. On the other hand, direct oxidative damage to DNA bases results in formation of adducts such as 8-hydroxy-20-deoxyguanosine (8OHdG), particularly at sites with poor protamine shielding [24, 25]. OS further activates the MAPK pathway, increasing p53 and caspase 3 expression and reducing bcl-2, thereby impairing maturation and promoting apoptosis [38]. OS activates intrinsic apoptotic pathways in spermatozoa, where externalization of phosphatidylserine is an early marker and SDF is a late marker of apoptosis [34]. This process is initiated through a mitochondrial-mediated pathway, where cytochrome c is released into the cytosol resulting in proteolytic activation of caspase 3, 6, and 7 [39, 40].


Fig. 2
Overview of the origins of sperm DNA fragmentation (SDF). SDF result from underlying mechanisms such as defective maturation, abortive apoptosis, and oxidative stress. Moreover, clinical (age, infection, cancer, hormonal imbalances, obesity, diabetes) and environmental (heat exposure, environmental toxins, radiation, smoking, drug abuse, diet) risk factors lead to SDF. MAPK: mitogen-activated protein kinase, ERK: extracellular signal-regulated kinase, JNK: c-JUN N-terminal kinase, ROS: reactive oxygen species, ART: assisted reproductive techniques.
Click for larger imageDownload as PowerPoint slide

2. Clinical and environmental risk factors of sperm DNA fragmentation

SDF increases with age, starting in reproductive years and doubling between the ages of 20 and 60 years [41, 42, 43]. This association has been attributed to higher exposure to OS, defective sperm chromatin packaging, and disordered apoptosis that occur with aging [44]. Clinical associations with increased SDF include varicocele, which induces testicular damage and SDF through increased intratesticular temperature and retrograde flow of renal and adrenal metabolites resulting in OS and apoptosis [45, 46]. Genitourinary infections and subsequent leukocytospermia increases ROS production, increasing SDF [47, 48, 49, 50, 51]. Increase in SDF has also been reported in men with testicular cancer and other malignancies, which is suggested to be secondary to the associated endocrine alterations or OS in these pathologies [52, 53, 54, 55].

Lifestyle and environmental factors induce SDF. Importantly, obese men have higher levels of OS and SDF compared to normal weight or overweight men [56, 57, 58]. Increased scrotal temperature, endocrine imbalance and chronic systemic inflammation are believed to be the mechanisms linking obesity with altered sperm function and reduced fertility potential. Indeed, studies have shown significant improvement in SDF and overall fertility with weight loss [59, 60]. Men with diabetes demonstrate higher levels of SDF due to OS, in association with the generation of advanced glycation end products [61, 62].

SDF and chromatin decondensation is observed with a subtle 2℃–3℃ increase in physiologic scrotal temperature [63, 64, 65, 66], partly mediated through OS induced apoptosis and elevated stress-inducible protein expression [67, 68, 69]. Increased scrotal temperature is induced by physical abnormalities such as cryptorchidism, retractile testes and varicocele, as well as in acute febrile illnesses and sedentary lifestyles [68, 70, 71, 72].

Some studies demonstrate increased SDF with air pollution [73, 74, 75]; while others have found no difference [76, 77, 78]. Exposure to heavy metals such as lead, cadmium [79, 80], fenvalerate (synthetic insecticide) [81] and organophosphorus pesticides [82] can cause DNA damage. The effect of occupational toxins depends on proximity and duration of exposure [83]. Bisphenol A and styrene found in synthetic rubber or polyesters, also alters sperm DNA integrity [84, 85, 86, 87].

Cigarette smoking negatively impacts DNA integrity [88, 89, 90, 91] due to tobacco metabolites [92] such as nicotine [93], cadmium [79, 94], lead [79, 80, 95] and benzopyrene [96]. Alcohol consumption can also increase SDF and cause apoptosis [97, 98, 99].

Electromagnetic waves, particularly from cell phones, increase mitochondrial ROS production and DNA adduct formation causing DNA damage [100, 101, 102]. Furthermore, radiation therapy for cancer can cause SDF [103].

These clinical and environmental risk factors increase the production of ROS by different mechanisms, leading to OS and ultimately result in SDF [104, 105, 106, 107, 108].

SPERM DNA FRAGMENTATION: SINGLE-VERSUS DOUBLE-STRAND BREAKS

DNA fragmentation is characterized by both SSBs and DSBs. In DNA with SSBs, the other strand can act as a template for replication. SSBs are caused by the action of abortive topoisomerase or DNA ligase activity adjacent to a lesion, which can covalently bind to phosphate and can thereby be fixed. The most commonly occurring lesions are base and sugar modifications and SSBs following oxidation, alkylation, deamination, and spontaneous hydrolysis [109]. When these lesions are not repaired, they can compromise the integrity of the genome [110]. Moreover, OS, lipid peroxidation and protein alteration may also lead to SSBs [111] (Fig. 3A). In general, DSBs are considered harmful to the genomic DNA as they result in genetic rearrangements. DSBs are produced from endogenous sources as a consequence of SSBs during the DNA replication process [112], collapsed replication forks [113], or increased levels of free radicals [112] (Fig. 3B). Furthermore, exogenous causes such as ionizing radiation, genotoxic chemicals, radiomimetic drugs can also lead to DSBs [112, 114, 115].


Fig. 3
(A) Main insults that result in DNA single strand breaks are abortive topoisomerase, free radicals, and DNA ligase activity adjacent to lesion. (B) Main insults that result in DNA double strand breaks are free radicals, collapsed replication forks, replication in DNA strand with single-stranded breaks, ionizing radiation, genotoxic chemicals, and radiomimetic drugs.
Click for larger imageDownload as PowerPoint slide

Both SSBs and DSBs present in sperm DNA can affect the overall fertility and reproductive outcomes. DSBs negatively affect embryo kinetics and implantation rates, and have been associated with recurrent miscarriages in couples without a female factor [116, 117]. In contrast, SSBs do not significantly impact embryo development or implantation rates [117]. Nonetheless, higher levels of SSBs are inversely related to the natural pregnancy outcome [118]. Thus, evaluation of SSB and DSB may provide important information during fertility evaluation of men [119]. Sperm DNA integrity can be determined using terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) assay and other direct tests, such as sperm chromatin structure assay (SCSA) and sperm chromatin dispersion (SCD). However, these assays cannot distinguish between SSBs and DSBs present in the DNA [117]. Depending on the methodology, i.e., either neutral (DSBs) or alkaline (SSBs and DSBs), this distinction can be made only by the Comet assay [120]. The two-tailed Comet assay can directly differentiate between the SSBs and DSBs [121]. On the other hand, the newest SDF test introduced for the immunodetection of gamma histone 2AX (γH2AX), can only assess DSBs [115]. The γH2AX is the phosphorylated form of γH2AX from the histone 2A family and is a highly specific and sensitive molecular marker of DSBs [122].

WHAT TEST SHOULD I ORDER?

Several assays are used for SDF evaluation in clinical practice (Table 1). The TUNEL assay is based on labelling free 3′-OH nicks with dUTP [123]. While Comet assay identifies SDF based on electrophoretic separation of DNA where damaged DNA forms a comet-like profile. In the SCD test, a distinct “halo” (dispersed DNA loops) is observed after removal of DNA-linked proteins, while no or small halos indicate DNA damage [124]. The SCSA uses metachromatic acridine orange, which fluoresces green and red after binding to double- (native) or single-stranded (damaged) DNA, respectively [125].


Table 1
Published SDF cut-off values for the prediction of pregnancy outcomes using different laboratory assays
Click for larger imageClick for full tableDownload as Excel file

As summarized in Table 1, several studies have attempted to identify clinical SDF cut-offs for the prediction of natural or ART-related pregnancy [126, 127, 128, 129, 130, 131]. Although there remains no unanimous consensus on a specific cut-off value, a recent meta-analysis suggests that a cut-off of 20% can potentially differentiate between fertile and infertile men [108]. Different SDF values are reported for prediction of pregnancy in natural conception or ART (in vitro fertilization [IVF], intracytoplasmic sperm injection [ICSI], or both) settings by analyzing native semen, sperm processed by swimup or density gradient centrifugation (DGC) as well as in cases where own or donor oocytes are used. Despite the heterogeneity of the published studies, the challenges related to the identification of unbiased cut-off values for the prediction of pregnancy and the use of SDF assays in clinical practice, it appears that the TUNEL assay is most commonly used [10], as it is accurate and reliable [132]. While it would be highly desirable if a globally accepted assay with strong predictive value would be performed by all clinics, in reality the choice of the SDF assay in individual clinics often depends on instrumentation availability, trained personnel and the cost of the assay to be performed in terms of reagents and run-time.

The diagnostic value of these tests for assisted reproduction can be increased by the evaluation of OS. A moderate correlation between ROS and SDF has been reported [133, 134, 135]. Decreased total antioxidant capacity, reflecting the amount of seminal antioxidants [136], has been associated with elevated SDF and male infertility [137] and an increased risk of spontaneous miscarriage [138]. By using oxidation reduction potential (ORP) as a measure of redox balance and SDF (by TUNEL) with cut-off values of 1.36 mV/106 sperm/mL and 32%, respectively, fertilization has been predicted with high sensitivity and specificity [139]. However, few studies report weak [140, 141] or no correlation between ORP and SDF [134], suggesting that ORP and SDF testing might reflect the general impact of seminal OS on sperm functions and specifically on DNA, respectively. Therefore, ORP cannot be recommended as a standalone test in substitution of SDF evaluation, considering that other factors, such as abortive apoptosis or defects in DNA protamination, can render spermatozoa more susceptible to OS and DNA damage, even at relatively low ROS levels [142]. Moreover, defects in the protamination and in DNA condensation can leave unligated nicks [143] while a faulty DNA rearrangement may lead to severe DNA damage [144].

WHICH PATIENTS ARE SUITABLE FOR SPERM DNA FRAGMENTATION TESTING?

The considerable research conducted in recent years has improved our understanding of the clinical scenarios where SDF testing is most beneficial. We recently published clinical practice guidelines endorsed by the Society of Translational Medicine recommending SDF testing in patients with unexplained infertility, recurrent pregnancy loss (RPL), and clinical varicocele, prior to undergoing ART and in patients exposed to lifestyle risk factors and environmental toxicants [145]. An updated evidence supporting these recommendations are presented in Table 2.


Table 2
Correlation between clinical outcomes and SDF testing: evidence-based report
Click for larger imageClick for full tableDownload as Excel file

For evidence-based reporting on SDF, the PubMed database was searched from the time of inception to December 2019. The search was limited to human studies published in English. The term ‘sperm DNA fragmentation’ was searched in combination with the following keywords using the Boolean expression “AND”: ‘intracytoplasmic sperm injection’, ‘fertilization in vitro’, ‘intrauterine insemination, ‘recurrent pregnancy loss’, ‘varicocele’, ‘idiopathic male infertility’, ‘unexplained male infertility’, ‘genital tract infections’, ‘male age’, ‘obesity’, ‘alcohol’, ‘smoking’, ‘air pollution’, ‘lifestyle’, ‘plastics’, ‘industrial’.

The inclusion criteria for the evidence-based reporting on SDF were (a) studies with male patients having primary or secondary infertility as target population and (b) studies reporting clinical outcome parameters including changes in semen parameters or SDF levels, fertilization, pregnancy, birth, and miscarriage rates.

The search yielded a total of 1,584 publications. The title and abstracts were cross-checked by three independent researchers and 251 articles were considered in this review. Relevant information was extracted from the studies that fulfilled the selection criteria and presented in Table 2.

1. Natural conception

As stated previously, sperm DNA integrity plays a crucial part in the fertilization process and in early embryo development, thereby directly influencing the likelihood of natural conception. Reports have linked SDF to low cleavage rates [146, 147] and to the arrest of embryonic development after the second cleavage state [148]. Using the SCSA on 215 Danish first pregnancy planners, Spanò et al [149] reported an inverse relationship between the level of SDF and probability of natural pregnancy in a menstrual cycle. Moreover, evidence linking SDF to natural pregnancy rates can be drawn from the meta-analysis by Zini [146] which included three studies and 616 couples and revealed that high SDF, determined by the SCSA test, was associated with failure to achieve natural pregnancy with an odds ratio (OR) of 7.01 (95% confidence interval [CI]=3.68–13.36).

2. Assisted reproductive technology outcomes

Numerous reports investigating the predictive role of SDF on ART outcomes have reported contradictory results [41, 88, 146, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164]. This controversy can be attributed to a number of factors, such as the study selection methods used by these reviews, heterogeneity of the conducted studies, differences in the SDF testing methods and female age and fertility status to name a few. With regards to intrauterine insemination (IUI), Chen et al [150] analyzed the results of 10 articles and demonstrated that high SDF levels were associated with significantly lower pregnancy (relative risk [RR]=0.34, 95% CI=0.22–0.52; p < 0.001) and delivery rates (RR=0.14, 95% CI=0.04–0.56; p < 0.001). This result was also echoed by two other meta-analyses reporting that patients with low SDF had an OR for clinical pregnancy ranging between 7.01 and 16 [41, 146]. However, a recent meta-analysis by Sugihara et al [151] analyzed the results of 3 studies and reported that while low SDF was associated with better pregnancy rates with a RR of 3.30 (95% CI=1.16–9.39), the test performance was low as it had a low positive predictive value (17%).

As for SDF impact on IVF/ICSI, various meta-analyses have been published assessing the rates of pregnancy, miscarriage and live birth. Four meta-analyses [146, 152, 154, 157] reported that high SDF was associated with lower pregnancy rates with conventional IVF with an OR ranging between 0.68 and 1.7. With regards to ICSI, only Simon et al [157] reported significantly lower pregnancy rates with high SDF, while the remaining three meta-analyses failed to find a significant association [146, 152, 154].

Live birth rate was examined by one meta-analysis and was found to be significantly lower in men with high SDF following both IVF and ICSI with a combined OR of 1.17 (95% CI=1.07–1.28; p=0.0005) [158].

Three meta-analyses examined the miscarriage rate following ART in relation to SDF [146, 153, 154]. Overall, high SDF was associated with greater risk for miscarriage following both IVF and ICSI with a combined OR ranging between 2.28 and 2.48.

Contrary to the abovementioned studies, two metaanalyses of slightly different design reported rather discouraging results. Cissen et al [155] analyzed 30 studies to assess the value of SDF in predicting the chance of ongoing pregnancy with IVF or ICSI. Overall, SDF testing had fair to good sensitivity with poor specificity. The authors constructed a hierarchical summary receiver operating characteristic curve, which reported fair predictive performance for TUNEL and Comet assays, while the predictive power for SCSA and SCD was poor. The authors concluded that the current SDF testing methods had a limited ability in predicting the chance of pregnancy in the context of ART. Furthermore, Collins et al [156] analyzed 13 studies having an extensive study heterogeneity and reported random effect model of the diagnostic OR rather than sensitivities and specificities. While the authors detected that sperm DNA integrity was significantly associated with pregnancy following IVF and ICSI with a diagnostic OR of 1.44, 95% CI=1.03–2.03; p=0.04 the likelihood ratios (LR(+)=1.23, LR(−)=0.81) were in a range suggesting that testing did not alter the outcome and was hence not clinically relevant. Subgroup analyses showed that the test accuracy was not materially affected by the testing method (TUNEL or SCSA) or the ART modality (IVF or ICSI).

Taking the abovementioned results all together, there is reasonable evidence to state that SDF is relevant in the context of ART. A high SDF value is associated with decreased pregnancy rate with IUI and IVF and with increased miscarriage rate following both IVF and ICSI.

3. Varicocele

Varicocele is the most common correctable cause of male infertility, prevalent in about 40% of men with primary infertility and up to 80% of men with secondary infertility [165]. Improper patient selection for varicocele ligation was an important reason for the controversy regarding the effect of treatment on pregnancy outcome. This has been resolved by indicating surgery only for patients with clinically evident disease and abnormal semen parameters [166]. However, even when proper patient selection is practiced, pregnancy is observed in only, 40% to 50% of patients following surgery [167]. Hence efforts have been made to refine the indications of surgery in varicocele patients and interest in SDF has emerged after finding a significant positive association with varicocele [168].

Studies have shown that men with varicocele have significantly higher levels of SDF than controls regardless of their fertility status, suggesting that varicocele is independently associated with impaired DNA integrity [168, 169, 170, 171, 172, 173, 174, 175]. A recent cross-sectional study was carried out on 2,399 men attending a fertility clinic, 16.3% (391/2,399) of whom were diagnosed with varicocele [171]. Men with varicocele had a significantly increased percentage of seminal SDF (p=0.03), abnormal chromatin packaging (p=0.001), and abnormal mitochondrial membrane potential (p=0.03) in comparison to men without varicocele. It is important to note that varicocele treatment is associated with a reduction in the SDF level. A meta-analysis conducted by Wang et al [176] invloving 12 studies (7 studies assessed SDF in patients with varicocele, while 6 studies determined the outcome of surgery) revealed that varicocele was associated with significantly higher levels of SDF compared with controls with a mean difference (MD) of 9.84% (95% CI=9.19–10.49; p<0.00001). Varicocele treatment resulted in significant reduction of SDF levels when compared to control group (MD of −3.37%; 95% CI −4.09 to −2.65; p<0.00001).

A recent review by Roque and Esteves [177] investigated 21 studies, including >1,200 subjects in whom the effect of varicocele ligation on SDF was assessed. The authors observed that all studies reported a significant decrease in SDF following varicocele ligation during a follow-up period ranging from 3 to 12 months. Few studies reported the pregnancy outcome following treatment and generally identified lower SDF values in couples who conceived compared with those who did not. Smit et al [178] utilized the SCSA in 49 patients before and after varicocelectomy and reported significant reduction in SDF values following surgery (MD=5%; p=0.019). Out of the 49 subjects, 18 (37%) conceived spontaneously and 11 (22%) conceived with ART. The SDF levels were significantly lower in patients who conceived spontaneously or with ART (26.6%±13.7%) in comparison to patients who did not conceive at all (37.3%±13.9%) (p=0.013). Another study by Ni et al [179] assessed the ratio between protamine 1 and 2 mRNAs (P1/P2) as well as SDF levels using PCR and SCSA, respectively, in 42 infertile men with varicocele and 10 fertile donors with normal semen parameters. The study group underwent varicocelectomy and pregnancy was achieved by 23.81% of patients 6 months after surgery. Compared with couples who failed to conceive following varicocelectomy, pregnant couples had significantly lower mean P1/P2 mRNA ratio and SDF levels.

4. Recurrent pregnancy loss

RPL, defined as spontaneous loss of 2 or more pregnancies. Prior to 20 weeks of gestation, has been linked to elevated levels of SDF in several investigations. Studies performed using different SDF testing methods such as SCD [180], TUNEL assay [181] and SCSA [182] reported significantly higher SDF levels among patients with RPL in comparison to normal controls [183]. Aiming to understand the male contribution to RPL, Tan et al [184] recently conducted a meta-analysis on 12 prospective and 2 retrospective studies including 530 men with RPL and 639 fertile controls. The study revealed a significant association between RPL and SDF with an average MD of 11.98, 95% CI 6.64–17.32; p<0.001 indicating that men with RPL had significantly higher SDF values than the control group. Similar result was reported during subgroup analysis according to the SDF testing method.

5. Idiopathic and unexplained male infertility

Unexplained male infertility (UMI) is a term given to couples who otherwise have a completely normal fertility evaluation. Studies have revealed that men with normal semen parameters may still have elevated levels of SDF. Oleszczuk et al [185] have shown that about 1 out of 5 men with unexplained infertility had a SDF level above 30%. Another prospective study conducted on 25 men with unexplained infertility revealed that a SDF level above 30%, measured by SCD, was detected in 29% of the subjects [185]. Similarly, idiopathic male infertility, a term given to describe men with one or more abnormality in semen parameters without an identifiable etiology, has been associated with high SDF. Studies have confirmed a significant inverse correlation between the SDF level and sperm count, motility and normal morphology [140, 186, 187]. A few comparative studies also have revealed that men with idiopathic male infertility tend to have significantly higher SDF than normal fertile controls [188] (Table 2).

6. High risk patients

Various studies have been conducted linking several lifestyle factors/environmental exposures to elevated levels of SDF [78, 94, 189, 190, 191, 192, 193, 194, 195, 196, 197, 198]. These factors include (i) Physical agents such as radiation and heat; (ii) Chemical agents such as cigarette smoke, airborne pollutants, and chemotherapeutic drugs; and (iii) Biological factors including sexually transmitted infections, increasing male age, elevated body mass index (BMI) and medical conditions such as insulin dependent diabetes [78, 94, 189, 190, 191, 192, 193, 194, 195, 196, 197, 199, 200, 201]. Elevated OS levels is believed to be the main mechanism resulting in SDF with these exposures. Moreover, occupational exposures have been considerably linked to SDF and altered fertility potential. Examples of such exposures include lead and cadmium [83], organochlorine pollutants found in pesticides [82], and bisphenol A, a compound widely utilized in plastic containers used in food and drink industries [86].

MANAGEMENT OF HIGH SPERM DNA FRAGMENTATION

1. Oral antioxidant therapy

Antioxidants play an important role in general health by scavenging excess free radicals and thus, preventing oxidative damage to macromolecules. However, the benefits of exogenous antioxidant therapy are less clear [202]. Clinicians commonly utilize antioxidant therapy to maintain redox balance by scavenging ROS [203]. Several clinical trials have demonstrated the positive effects of antioxidants on SDF in infertile men (Table 3) [204, 205, 206, 207, 208]. However, with no validated guidelines on antioxidant supplementation, they are frequently used empirically. Antioxidants can be easily purchased over the counter and are commonly considered safe. However, excess antioxidant supplementation may have a paradoxical effect on OS and SDF, a condition referred to as reductive stress [209]. As a result, the indiscriminate use of oral antioxidants in men without elevated OS should be avoided [210].


Table 3
Therapeutic interventions for SDF: evidence based report
Click for larger imageClick for full tableDownload as Excel file

2. Control of infections/inflammation/leukocytospermia

Among infertile men, the incidence of infection ranges from 2% to 18% [211]. Sexually transmitted infections or prostatitis are associated with elevated OS and leukocytospermia, which may result in elevated SDF and impaired fertility [212, 213]. Antibiotic therapy has been reported to be effective in treating infection-induced elevated SDF levels (Table 3) [47]. Moreover, empirical antibiotic therapy for leukocytospermia may improve natural pregnancy rates [214].

3. Varicocelectomy

Varicocele has been consistently associated with increased SDF values. It has been established that varicocele repair can improve OS markers and reduce SDF indices [11]. Current data supports the value of varicocele repair in reducing SDF and improving fertility (Table 3). In a systematic review of 21 studies evaluating the effect of varicocelectomy on SDF, all studies reported a significant decrease in SDF by an average of approximately 8% [177]. Moreover, varicocele repair has demonstrated improvements in pregnancy success in both natural conception and assisted reproduction by way of improved SDF indices [178]. Given these observations, the association between palpable varicocele and SDF should be considered, and varicocelectomy discussed with patients as a potential solution to improving fertility.

4. Lifestyle modifications

Exposure to environmental and lifestyle factors have far-reaching implications on male fertility. Current data has consistently associated smoking with higher SDF values when compared to non-smokers [91, 99, 191, 215], however no study has yet evaluated the impact of smoking cessation on SDF. There have also been numerous environmental factors such as airborne pollutants, ionizing radiation, and pesticides linked with increased SDF values [74, 82, 193, 216, 217]. Several studies have demonstrated higher SDF in obese men, yet a recent meta-analysis found no robust association between BMI and SDF [218]. No concrete evidence in lifestyle modification impact on SDF exists [219], however, weight loss and dietary changes have been proposed to benefit SDF indices in patients [220, 221] (Table 3).

5. Short ejaculatory abstinence

The negative impact of prolonged ejaculatory abstinence (EA) on SDF has been reported without significant detrimental effect on conventional semen parameters [222, 223]. Therefore, short-term recurrent ejaculation may be a simple noninvasive maneuver to improve SDF. Although the beneficial effect of short EA on natural conception is unclear, application of the technique to assisted reproduction may have its value [224, 225, 226]. In addition to higher pregnancy rates in ICSI, recurrent ejaculation has been associated with a significantly lower SDF [227] (Table 3).

6. Sperm processing and preparation

Laboratory conditions (i.e., prolonged incubation, centrifugation, cryopreservation and use of different media) can significantly impact SDF by increasing OSmediated DNA damage [228, 229, 230, 231]. Conventional (swimup, DGC) and advanced techniques can select sperm with low levels of SDF [232, 233, 234, 235, 236] (Table 3). Magneticactivated cell sorting (MACS), based on the detection of phosphatidylserine [237], shows a better selection alone [238, 239] or in combination with DGC [240, 241, 242, 243]. Intracytoplasmic morphologically selected sperm injection (IMSI) uses high magnification to select the most morphologically normal sperm, as the presence of vacuoles in the nuclear region has been associated with high SDF [244, 245]. Other approaches include the physiological intracytoplasmic sperm injection (PICSI), based on sperm binding to hyaluronic acid, and microfluidic devices, allowing sperm migration along microchannels [246, 247, 248, 249].

7. Use of testicular sperm for intracytoplasmic sperm injection

Testicular sperm has been explored as a treatment option for high SDF based on the finding of lower SDF in testicular sperm than ejaculated sperm [250, 251], and better ICSI outcome [12, 252, 253]. However, surgical sperm retrieval [254] carries risk of anesthetic and surgical complications. Furthermore, possible higher aneuploidy rate in testicular sperm is a concern [255] despite a recent report of opposing view [256]. Therefore, the use of testicular sperm in clinical management of nonazoospermic patients with high SDF is still debated.

CLINICAL CASE REPORTS

1. Case 1

A 37-year-old male, presented to the male infertility unit complaining of primary infertility of 3 years duration. He is a navy lieutenant and is physically fit. He does not have a history of recent febrile illness, genitourinary infections or trauma. He does not have a significant past medical or surgical history. He smokes half a pack of cigarettes a day for the past 15 years. There is no family history of infertility. His wife is 26 years old with regular menses and normal fertility evaluation. There is no consanguinity between the couple. On physical examination, he was of normal BMI (26 kg/m2). Genital examination revealed normal phallus, normal testis size, palpable vasa bilaterally and no palpable varicocele. An outside semen analysis demonstrated a volume of 3 mL, sperm concentration of 11 million/mL, total motility of 40% (progressive motility 20%) and normal morphology of 10%.

Repeat semen analysis with SDF testing performed at our center demonstrated a volume of 4.5 mL, sperm concentration 9 million/mL, total motility 30% (progressive motility 10%), normal morphology of 3% (WHO, 2010) and SDF of 45% (using the SCD test [Halosperm], normal<30%). His serum hormone levels were as follows: testosterone 17.5 nmol/L (normal=10.4–30.86 nmol/L), follicle stimulating hormone (FSH) 2.5 IU/L (normal=1.5–12.4 IU/L), luteinizing hormone (LH) 2 IU/L (normal=1.7–8.6 IU/L), estradiol 122 pmol/L (normal=94.8–223 pmol/L), and prolactin 245 mIU/L (normal=85–323 mIU/L). Scrotal ultrasound demonstrated normal testicular volume echogenicity, and vascularity and absence of epididymal cysts and varicoceles.

The patient was diagnosed with idiopathic oligoasthenoteratozoospermia and high SDF. He had a lifestyle risk factor and was counselled about the importance of smoking cessation on his overall health and fertility potential.

He was prescribed the following antioxidants: vitamin C 500 mg twice daily, L-carnitine+zinc 1,000 mg twice daily, and folic acid 0.5 mg once daily for 3 months.

On the 3-month follow-up visit, a repeat semen testing showed a volume of 3 mL, sperm concentration of 17 million/mL, total motility 45% (progressive motility 25%), normal morphology 5%, and SDF 26%. There was still no pregnancy and hence, the couple were advised to undergo IUI. The patient was kept on vitamin C and L-carnitine+zinc regimen.

The procedure was performed 5 weeks following the last patient visit. The prewash total motile sperm count was 22.5 million and the post-wash total motile sperm count was 13 million. The patient was seen in the clinic 6 weeks following his IUI and reported that his wife was pregnant.

2. Case 2

A 41-year-old male, presented for fertility evaluation after failure of conception for 3 years. His past medical and surgical history were unremarkable. He did not smoke or consume alcohol. On physical examination, the patient had normal built (height 176 cm, weight 82 kg, BMI 26.5 kg/m2). On genital examination, both testes were normally descended with normal size and consistency, both epididymes were normal, vasa deferentia could be felt bilaterally, and no varicocele could be appreciated either side. The spouse was 32 years old with regular menses, no gynecological problems and normal ovarian reserve (anti-mullerian hormone: 18.9 pmol/L, normal=0.071–52.4 pmol/L).

Semen analysis demonstrated a volume of 2.5 mL, sperm concentration of 34 million/mL, total motility of 8%, 0% progressive motility and 5% normal morphology. SDF testing was performed using the Halosperm Kit and was found to be high (90%). Hormonal profile assessment showed normal levels of testosterone, FSH, LH, prolactin and estradiol. The patient was given antioxidants in the form of L-carnitine 1,000 mg+zinc twice daily, vitamin C 1,000 mg once daily, co-enzyme Q10 and selenium for 3 months and on repetition of SDF, it was still high (85%). The couple were counseled and decided to go for a trial of ICSI using ejaculated sperm. The female was started with standard long protocol. On the day of ICSI, 16 cumulus-oophorus complexes were collected, 13 of which were in metaphase II (MII) and were used in ICSI. After 24 hours only one oocyte was fertilized and at day 3, it showed no division therefore no embryo transfer was done.

After 4 months, SDF was still elevated (85%) and the couple were scheduled for a second ICSI trial using testicular sperm which was retrieved by testicular sperm aspiration on day of ICSI. In total, 22 oocytes were collected, 15 of which were MII. At 24 hours, 9 oocytes were fertilized. Two embryos were transferred on day 5. Pregnancy test was positive after 2 weeks and the spouse delivered a healthy girl.

3. Case 3

A 44-year-old male, presented for fertility evaluation after failure of conception for 6 years. He had an unremarkable past medical and surgical history. He was a non-smoker and non-drinker. On physical examination, the patient has normal built (height 177 cm, weight 77 kg, BMI 24.6 kg/m2). On genital examination, both testes were normally descended with normal size and consistency, both epididymis were normal, vasa deferentia could be felt bilaterally, and varicocele could be appreciated on both sides clinically (left grade III and right grade I). The spouse was 30 years old with regular menses and no gynecological problems. The couple performed one IUI trial 3 years ago but it was unsuccessful.

Semen analysis showed oligoasthenoteratozoospermia with a sperm concentration of 6 million/mL, total motility of 34%, 4% progressive motility, and 2% normal morphology. SDF testing with the Halosperm Kit was high (45%). Hormonal profile assessment showed normal levels of testosterone, FSH, LH, prolactin and estradiol. Scrotal ultrasound confirmed bilateral varicocele with vein diameters of 4.8 mm and 3.2 mm on left and right sides, respectively. The couple were counseled on treatment options and consented to proceed with surgical varicocelectomy. Bilateral microsurgical subinguinal varicocelectomy was performed without any complications.

After 3 months, the patient repeated the semen analysis which demonstrated improvement but with continued oligoasthenoteratozoospermia with a sperm concentration of 9 million/mL, total motility of 65%, 8% progressive motility, and 3% normal morphology. SDF was normalized (25%). The couple were counseled for assisted conception, but they opted to try for natural conception for another 3 months. At 6 months following surgery, they achieved a spontaneous pregnancy and subsequently delivered a healthy girl.

4. Case 4

A 34-year-old male, presented for fertility evaluation. His wife was 33 years old with regular menses and no gynecological problems. They were married for 8 years and had a 6.5-year-old boy who was conceived spontaneously. The husband had an unremarkable past medical history. He underwent left orchidectomy following failed orchiopexy for an intra-abdominal left undescended testis at the age of 6 years. He was a nonsmoker and did not consume alcohol. On physical examination, the patient had normal built (height 182 cm, weight 98 kg, BMI 29.6 kg/m2). On genital examination, the left scrotal sac was empty and underdeveloped. The right testis, epididymis, and vas deferens were normal, and there was no palpable varicocele.

Semen analysis showed a sperm concentration of 14 million/mL, total motility of 45%, 15% progressive motility and 4% normal morphology. SDF was tested twice using Halosperm Kit and was high (47% and 49%). ORP was assessed using the MiOXSYS system and was high (2.9 mV/106 sperm/mL, normal=1.34 mV/106 sperm/mL). Hormonal profile assessment showed normal levels of testosterone, FSH, LH, prolactin and estradiol. The patient was given antioxidants (containing mainly selenium, L-carnitine, L-arginine, Coenzyme Q10, Lycopene, N acetyle l-cysteine, vitamin C, and E) for 3 months. On repetition of semen analysis, it showed 31 million/mL, total motility of 50%, 25% progressive motility and 8% normal morphology, while SDF (25%) and ORP (1.2 mV/106 sperm/mL) normalized. One month later, his wife achieved a spontaneous pregnancy and she delivered a healthy boy.

EXPERT RECOMMENDATIONS ON SPERM DNA FRAGMENTATION TESTING

The extensive literature search conducted in this review reveals that SDF significantly impacts male fertility and its testing in specific clinical circumstances may augment the treatment strategy resulting in better outcomes. Accordingly, a clinical algorithm is set forth by this expert panel to elucidate the application of SDF testing in clinical practice (Fig. 4). Patients presenting with infertility should be evaluated with a complete medical and reproductive history, undergo physical examination by a reproductive specialist or urologist and provide at least two semen specimens for conventional analysis [257, 258, 259].


Fig. 4
Clinical algorithm to elucidate the applications of sperm DNA fragmentation (SDF) testing in clinical practice. ICSI: intracytoplasmic sperm injection.
Click for larger imageDownload as PowerPoint slide

Men with idiopathic and UMI, RPL, and modifiable lifestyle risk factors should undergo SDF testing (grade C recommendation). This recommendation is based on the evidence linking high SDF levels in the abovementioned conditions. It is also aimed at providing pertinent treatment strategies directed at lowering SDF levels. Oral antioxidant therapy may be considered in these regards (grade C recommendation). While its benefit in alleviating SDF and improving live birth rates in infertile men has been reported by a Cochrane meta-analysis [260], further research is needed to refine the ideal candidates and treatment regimen.

Diet modification and weight reduction may help in reducing SDF (grade C recommendation). However, further research is needed to confirm the role of lifestyle modifications in improving sperm DNA integrity and possibly translate into better reproductive results. Nonetheless, the information provided by SDF testing might help to monitor patient compliance and treatment prognosis.

Another indication for SDF testing is in patients who are diagnosed with clinical varicocele (grade C recommendation). The findings of higher SDF in both fertile and infertile men with varicocele than controls [168] and significant decrease in SDF levels after varicocele repair [261] provide the rationale of SDF testing in refining the selection of varicocelectomy candidates. In addition, reduction in SDF seems to translate into better reproductive outcomes [262, 263, 264]. Although the association between SDF and high-grade varicocele is much stronger, patients with low-grade varicocele had achieved improvement in natural pregnancy rate that were similar to those with high-grade varicocele after surgery [265].

SDF testing should also be offered to infertile couples prior to initiating or after failure of IUI/IVF (grade C recommendation). The relationship between SDF and ART outcomes has been extensively investigated. Controversies persist in view of heterogeneous nature of the studies [16, 266]. In general, high SDF is one of the etiologies in patients with recurrent IUI or IVF failure [267]. In contrast to the association between SDF and IUI/IVF outcomes, there is compelling evidence suggesting that SDF has a negligible effect on ICSI outcome measures [154, 158, 268]. These results signify the potential role of ICSI in the treatment of men with high SDF. Patients with persistently high SDF result should be directed towards ICSI, such recommendation will avoid unnecessary delay in definitive treatment which is particularly important in couples with limited reproductive window (grade C recommendation).

Finally, SDF testing is indicated in couples with recurrent miscarriage following ICSI (grade C recommendation). While high levels of SDF appear not have a significant impact on ICSI pregnancy rates [146, 152, 154, 157], a greater risk of miscarriage following ICSI has been reported by several meta-analyses [146, 153, 154]. A number of interventions have been explored in the context of ICSI to reduce SDF levels and consequently achieve a better outcome. Various sperm selection methods (swim-up, DGC, MACS, IMSI, PICSI) are able to identify sperm with intact DNA integrity for injection [237, 240, 241, 242, 243, 244, 246]. The significantly lower SDF levels in testicular compared to ejaculated sperm supports the use sperm harvested from testis as a plausible maneuver to bypass sperm DNA damage which occurs during the epididymal transit [250]. A metaanalysis of five studies favored the use of testicular sperm by demonstrating better clinical pregnancy and live birth rates [12]. The utilization of testicular sperm is further supported by recent reports and better reproductive outcomes that have been reported in both oligozoospermic and normozoospermic men with prior ICSI failure [269, 270]. Nonetheless, the invasive nature of sperm retrieval procedures and the higher rates of sperm aneuploidy with testicular sperm can be considered as potential disadvantages for this treatment approach which certainly warrants further investigation [271, 272].

STRENGTHS-WEAKNESSES-OPPORTUNITIES-THREATS (SWOT) ANALYSIS ON THE CLINICAL UTILITY OF SPERM DNA FRAGMENTATION TESTING IN SPECIFIC MALE INFERTILITY SCENARIOS

SWOT analysis, a system that was originally developed for financial studies, has been recently applied to health sciences. It explores the strengths and weaknesses of a given method in an attempt to identify the threats and opportunities accessible to overcome certain gaps hindering its broad application. Studies included in this review (Table 2) were analyzed using the SWOT method to understand the perceived advantages and drawbacks for the clinical utility of SDF in specific clinical scenarios (Fig. 5).


Fig. 5
Strengths-Weaknesses-Opportunities-Threats (SWOT) analysis on the clinical utility of sperm DNA fragmentation (SDF) testing in specific male infertility scenario. ART: assisted reproductive techniques.
Click for larger imageDownload as PowerPoint slide

1. Strengths

SDF testing can serve as an ancillary test to conventional semen analysis in specific clinical scenarios. Evidence indicates that higher levels of SDF are observed in patients who are unable to conceive naturally [149, 273, 274, 275], who present with UMI/idiopathic infertility [185, 188, 276, 277, 278, 279, 280, 281, 282], have RPL [116, 138, 180, 181, 182, 183, 283, 284, 285, 286, 287, 288, 289, 290, 291, 292, 293, 294, 295], are diagnosed with varicocele [169, 170, 171, 172, 173, 174, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305], have a negative ART outcome [13, 41, 88, 117, 306, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 328, 329, 330] and who are found to have lifestyle/environmental risk factors [42, 47, 56, 65, 74, 82, 84, 88, 190, 191, 192, 193, 195, 196, 197, 243, 331, 332, 333, 334, 335, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349].

The widespread use of SDF testing has been hampered by the belief that no effective treatment exists to alleviate high SDF in clinical practice. On the contrary, studies have shown that a number of interventions can be utilized in this regard. Examples of such interventions include recurrent ejaculation to shorten the abstinence time [222, 227, 350, 351, 352], oral antioxidant therapy [205, 207, 208, 353, 354, 355, 356, 357, 358, 359, 360, 361, 362], performing varicocelectomy for patients with clinical varicocele [168, 176, 177, 179, 263, 264, 360, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 374, 375, 376, 377, 378, 379, 380, 381, 382], treating genitourinary infections when diagnosed [47], and utilizing advanced sperm selection techniques for ICSI such as PICSI/IMSI [383, 384, 385] or using testicular sperm instead of ejaculated sperm [251, 252, 269, 386, 387].

2. Weaknesses

Perhaps the main limitation of SDF testing is the lack of a definitive cut-off value above which a sample is considered anomalous. It is worth mentioning that various SDF thresholds may be determined based on the predicted outcome measure (fertility/infertility, ART success/failure, etc.). Indeed, several cut-off values were reported having a fair to good overall accuracy in predicting various outcome measures (Table 1). Despite the differences in the reported cut-offs, a recent meta-analysis by Santi et al. compared the SDF results of four different assays (TUNEL, SCD, SCSA, and Comet) between 2,883 infertile men and 1,294 fertile men. The authors identified a SDF cut-off of 20% which had a good predictive power in differentiating between fertile and infertile men with a sensitivity of 79% and a specificity of 86% (area under the curve=0.844) [108].

Another weakness for the utility of SDF testing is the existing moderate to low evidence in support of its use in the above-mentioned clinical scenarios. The heterogenous nature of the conducted studies and the scarcity of randomized clinical trials are possibly the main reasons behind the obtained level of evidence. Furthermore, few contradictory studies have been reported in almost every clinical scenario. A number of studies failed to find a significant association between high levels of SDF and UMI/idiopathic infertility [190, 388], RPL [389, 390, 391, 392], and likelihood of conception whether natural [381], or following ART [314, 393, 394, 395, 396, 397, 398, 399, 400, 401, 402, 403, 404, 405, 406, 407, 408, 409, 410]. While 50%–60% of patients with varicocele have elevated SDF levels, it is not uncommon to find a normal SDF result in infertile men with varicocele who might have a conventional semen parameter abnormality. As for lifestyle/environmental risk factors, no solid evidence exists to support the benefit of lifestyle modification on the SDF level [199, 411, 412].

3. Threats

The lack of sufficient high-quality evidence supporting the utility of SDF testing resulted in international societies (American Society for Reproductive Medicine, American Urologic Association, European Association of Urology [EAU]) not to recommend its routine use for the evaluation of male infertility. However, since many confounding factors can impact the likelihood of conception, it is not uncommon in the field of reproduction to provide recommendations for diagnostic tests based on lower quality of evidence. Nonetheless, the increasing number of publications exploring the utility of SDF testing in recent years should provide enough fuel for an update to reproductive society guidelines. This is recently witnessed in the latest update of the EAU guidelines on male infertility which recommends SDF testing for the assessment of couples with RPL following natural or ART conceptions and in men with unexplained infertility [259].

Case scenarios are commonly used in medical literature to describe a certain clinical condition. However, they may not accurately represent all the possible presentations that might be seen in the clinic. Despite this, we have utilized this method to personalize the message giving it a clinical perspective.

Finally, the cost of SDF testing ranges between $150–300 (Table 4) which is another important factor limiting its routine use in clinical practice. However, cost is also a major drawback to several fertility related therapeutic interventions that are usually not covered by medical insurance [413]. While SDF testing may be considered an additional cost for patients undergoing fertility treatments, such as ART or varicocelectomy, understanding the circumstances where this assay is most beneficial should help in improving the outcome of treatment and may possibly impact the overall treatment cost.

4. Opportunities

Further studies of adequate power and controlled design are necessary to enhance our understanding of the clinical utility of SDF. This review inspected the available literature with regards to various applications for SDF testing in clinical practice. However, a number of gaps remain and are considered potential areas of research. These areas are particularly involved with demonstrating the impact of interventions on SDF reduction and more importantly on fecundity.

CONCLUSIONS

SDF is detrimental for normal fertilization, embryo development and success of ART and therefore, SDF testing is increasingly being utilized in the evaluation of male infertility. SDF can be induced endogenously by defective maturation and abortive apoptosis occurring within the testis, or by OS throughout the male reproductive tract. It can also result from exogenous sources including clinical disease states (varicocele, cancer, diabetes), lifestyle risk factors (smoking, alcoholism, obesity), and environmental exposures (air pollution, pesticides, industrial chemicals). Various SDF testing methods are available; while a single specific cut-off value has not been unanimously identified, a threshold of 20% is believed to be hold a good discriminative accuracy between fertile and infertile men. The thorough literature review presented in this manuscript identifies specific clinical scenarios where SDF testing is most beneficial. These include patients with unexplained and idiopathic infertility, RPL, varicocele, opting for ART and in those with lifestyle/environmental risk factors. A number of therapeutic interventions can be undertaken in patients with high SDF result to improve their likelihood of conception. Recurrent ejaculation, antioxidant therapy, lifestyle modification, varicocelectomy, and the use of advanced sperm selection techniques or testicular sperm for ICSI are examples of treatment methods that can be utilized in such patients.

Key points

1) Sperm DNA integrity is crucial for fertilization and development of healthy offspring.

2) SDF results from defective maturation, abortive apoptosis and OS and can be induced by a number of disease states and lifestyle/environmental exposures.

3) There are several assays available to assess sperm DNA damage and most commonly utilized tests include TUNEL, SCD, SCSA and single cell gel electrophoresis assay.

4) Evidence indicates that SDF testing is most beneficial in patients with unexplained and idiopathic infertility, RPL, varicocele, opting for ART and in those with lifestyle/environmental risk factors.

5) High SDF fragmentation can be treated by recurrent ejaculation, antioxidant therapy, lifestyle modification, varicocelectomy, and the use of advanced sperm selection techniques or testicular sperm for ICSI.

Notes

Conflict of Interest:The authors have nothing to disclose.

Author Contribution:

  • Conceptualization: AA.

  • Writing — original draft: all the authors.

  • Writing — review & editing: all the authors.

ACKNOWLEDGEMENTS

Authors are thankful to the artists from the Cleveland Clinic's Center for Medical Art & Photography for their help with the illustrations. The study was supported by the American Center for Reproductive Medicine (Andrology Research Fund #500000105879).

References
Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, et al. The international glossary on infertility and fertility care, 2017. Fertil Steril 2017;108:393–406.
Choy JT, Eisenberg ML. Male infertility as a window to health. Fertil Steril 2018;110:810–814.
Wang C, Swerdloff RS. Limitations of semen analysis as a test of male fertility and anticipated needs from newer tests. Fertil Steril 2014;102:1502–1507.
Agarwal A, Allamaneni SS. Sperm DNA damage assessment: a test whose time has come. Fertil Steril 2005;84:850–853.
Guzick DS, Overstreet JW, Factor-Litvak P, Brazil CK, Nakajima ST, Coutifaris C, et al. National Cooperative Reproductive Medicine Network. Sperm morphology, motility, and concentration in fertile and infertile men. N Engl J Med 2001;345:1388–1393.
Simon L, Emery BR, Carrell DT. Review: diagnosis and impact of sperm DNA alterations in assisted reproduction. Best Pract Res Clin Obstet Gynaecol 2017;44:38–56.
Baskaran S, Cho CL, Agarwal A. Role of sperm DNA damage in male infertility assessment. In: Rizk B, Agarwal A, Sabanegh ES Jr, editors. Male infertility in reproductive medicine: diagnosis and management. Boca Raton: CRC Press; 2019. pp. 205.
Agarwal A, Prabakaran S, Allamaneni S. What an andrologist/ urologist should know about free radicals and why. Urology 2006;67:2–8.
Aitken RJ, Curry BJ. Redox regulation of human sperm function: from the physiological control of sperm capacitation to the etiology of infertility and DNA damage in the germ line. Antioxid Redox Signal 2011;14:367–381.
Baskaran S, Agarwal A, Panner Selvam MK, Finelli R, Robert KA, Iovine C, et al. Tracking research trends and hotspots in sperm DNA fragmentation testing for the evaluation of male infertility: a scientometric analysis. Reprod Biol Endocrinol 2019;17:110
Esteves SC, Santi D, Simoni M. An update on clinical and surgical interventions to reduce sperm DNA fragmentation in infertile men. Andrology 2020;8:53–81.
Esteves SC, Roque M, Bradley CK, Garrido N. Reproductive outcomes of testicular versus ejaculated sperm for intracytoplasmic sperm injection among men with high levels of DNA fragmentation in semen: systematic review and meta-analysis. Fertil Steril 2017;108:456–467.e1.
Larson KL, DeJonge CJ, Barnes AM, Jost LK, Evenson DP. Sperm chromatin structure assay parameters as predictors of failed pregnancy following assisted reproductive techniques. Hum Reprod 2000;15:1717–1722.
Robinson L, Gallos ID, Conner SJ, Rajkhowa M, Miller D, Lewis S, et al. The effect of sperm DNA fragmentation on miscarriage rates: a systematic review and meta-analysis. Hum Reprod 2012;27:2908–2917.
Aitken RJ. DNA damage in human spermatozoa; important contributor to mutagenesis in the offspring. Transl Androl Urol 2017;6 Suppl 4:S761–S764.
Agarwal A, Majzoub A, Esteves SC, Ko E, Ramasamy R, Zini A. Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios. Transl Androl Urol 2016;5:935–950.
Muratori M, Marchiani S, Tamburrino L, Baldi E. Sperm DNA fragmentation: mechanisms of origin. In: Baldi E, Muratori M, editors. Genetic damage in human spermatozoa. 2nd ed. Cham: Springer; 2019. pp. 75-85.
O'Donnell L. Mechanisms of spermiogenesis and spermiation and how they are disturbed. Spermatogenesis 2015;4:e979623
McPherson S, Longo FJ. Chromatin structure-function alterations during mammalian spermatogenesis: DNA nicking and repair in elongating spermatids. Eur J Histochem 1993;37:109–128.
Rousseaux S, Boussouar F, Gaucher J, Reynoird N, Montellier E, Curtet S, et al. Molecular models for post-meiotic male genome reprogramming. Syst Biol Reprod Med 2011;57:50–53.
Shaman JA, Prisztoka R, Ward WS. Topoisomerase IIB and an extracellular nuclease interact to digest sperm DNA in an apoptotic-like manner. Biol Reprod 2006;75:741–748.
Lewis SE, Aitken RJ. DNA damage to spermatozoa has impacts on fertilization and pregnancy. Cell Tissue Res 2005;322:33–41.
Oliva R. Protamines and male infertility. Hum Reprod Update 2006;12:417–435.
Abbotts R, Wilson DM 3rd. Coordination of DNA single strand break repair. Free Radic Biol Med 2017;107:228–244.
Aitken RJ, Whiting S, De Iuliis GN, McClymont S, Mitchell LA, Baker MA. Electrophilic aldehydes generated by sperm metabolism activate mitochondrial reactive oxygen species generation and apoptosis by targeting succinate dehydrogenase. J Biol Chem 2012;287:33048–33060.
Marchiani S, Tamburrino L, Muratori M, Baldi E. Spermatozoal chromatin structure: role in sperm functions and fertilization. In: Arafa M, Elbardisi H, Majzoub A, Agarwal A, editors. Genetics of male infertility: a case-based guide for clinicians. Cham: Springer; 2020. pp. 39-55.
Henkel R, Leisegang K. Origins of sperm DNA damage. In: Parekattil SJ, Esteves SC, Agarwal A, editors. Male infertility: contemporary clinical approaches, andrology, ART and antioxidants. 2nd ed. Cham: Springer; 2020. pp. 361-375.
Boekelheide K. Mechanisms of toxic damage to spermatogenesis. J Natl Cancer Inst Monogr 2005;(34):6–8.
Martin-Hidalgo D, Bragado MJ, Batista AR, Oliveira PF, Alves MG. Antioxidants and male fertility: from molecular studies to clinical evidence. Antioxidants (Basel) 2019;8:89
Shukla KK, Mahdi AA, Rajender S. Apoptosis, spermatogenesis and male infertility. Front Biosci (Elite Ed) 2012;4:746–754.
Green DR, Droin N, Pinkoski M. Activation-induced cell death in T cells. Immunol Rev 2003;193:70–81.
Sakkas D, Mariethoz E, St John JC. Abnormal sperm parameters in humans are indicative of an abortive apoptotic mechanism linked to the Fas-mediated pathway. Exp Cell Res 1999;251:350–355.
Łuczaj W, Skrzydlewska E. DNA damage caused by lipid peroxidation products. Cell Mol Biol Lett 2003;8:391–413.
Platt N, da Silva RP, Gordon S. Recognizing death: the phagocytosis of apoptotic cells. Trends Cell Biol 1998;8:365–372.
Moazamian R, Polhemus A, Connaughton H, Fraser B, Whiting S, Gharagozloo P, et al. Oxidative stress and human spermatozoa: diagnostic and functional significance of aldehydes generated as a result of lipid peroxidation. Mol Hum Reprod 2015;21:502–515.
Aitken RJ, Bronson R, Smith TB, De Iuliis GN. The source and significance of DNA damage in human spermatozoa; a commentary on diagnostic strategies and straw man fallacies. Mol Hum Reprod 2013;19:475–485.
Badouard C, Ménézo Y, Panteix G, Ravanat JL, Douki T, Cadet J, et al. Determination of new types of DNA lesions in human sperm. Zygote 2008;16:9–13.
Ranawat P, Bansal MP. Apoptosis induced by modulation in selenium status involves p38 MAPK and ROS: implications in spermatogenesis. Mol Cell Biochem 2009;330:83–95.
Desagher S, Martinou JC. Mitochondria as the central control point of apoptosis. Trends Cell Biol 2000;10:369–377.
Pradeepa MM, Rao MR. Chromatin remodeling during mammalian spermatogenesis: role of testis specific histone variants and transition proteins. Soc Reprod Fertil Suppl 2007;63:1–10.
Bungum M, Humaidan P, Spano M, Jepson K, Bungum L, Giwercman A. The predictive value of sperm chromatin structure assay (SCSA) parameters for the outcome of intrauterine insemination, IVF and ICSI. Hum Reprod 2004;19:1401–1408.
Alshahrani S, Agarwal A, Assidi M, Abuzenadah AM, Durairajanayagam D, Ayaz A, et al. Infertile men older than 40 years are at higher risk of sperm DNA damage. Reprod Biol Endocrinol 2014;12:103
Pino V, Sanz A, Valdés N, Crosby J, Mackenna A. The effects of aging on semen parameters and sperm DNA fragmentation. JBRA Assist Reprod 2020;24:82–86.
Petersen CG, Mauri AL, Vagnini LD, Renzi A, Petersen B, Mattila M, et al. The effects of male age on sperm DNA damage: an evaluation of 2,178 semen samples. JBRA Assist Reprod 2018;22:323–330.
Zorgniotti AW, Macleod J. Studies in temperature, human semen quality, and varicocele. Fertil Steril 1973;24:854–863.
Goldstein M, Eid JF. Elevation of intratesticular and scrotal skin surface temperature in men with varicocele. J Urol 1989;142:743–745.
Gallegos G, Ramos B, Santiso R, Goyanes V, Gosálvez J, Fernández JL. Sperm DNA fragmentation in infertile men with genitourinary infection by Chlamydia trachomatis and Mycoplasma. Fertil Steril 2008;90:328–334.
Babazadeh Z, Razavi S, Tavalaee M, Deemeh MR, Shahidi M, Nasr-Esfahani MH. Sperm DNA damage and its relation with leukocyte DNA damage. Reprod Toxicol 2010;29:120–124.
Agarwal A, Mulgund A, Alshahrani S, Assidi M, Abuzenadah AM, Sharma R, et al. Reactive oxygen species and sperm DNA damage in infertile men presenting with low level leukocytospermia. Reprod Biol Endocrinol 2014;12:126
Moubasher A, Sayed H, Mosaad E, Mahmoud A, Farag F, Taha EA. Impact of leukocytospermia on sperm dynamic motility parameters, DNA and chromosomal integrity. Cent European J Urol 2018;71:470–475.
Pratap H, Hottigoudar SY, Nichanahalli KS, Rajendran S, Bheemanathi HS. Sperm DNA integrity in leukocytospermia and its association with seminal adenosine deaminase. J Hum Reprod Sci 2019;12:182–188.
Meseguer M, Santiso R, Garrido N, Fernandez JL. The effect of cancer on sperm DNA fragmentation as measured by the sperm chromatin dispersion test. Fertil Steril 2008;90:225–227.
Marchlewska K, Filipiak E, Walczak-Jedrzejowska R, Oszukowska E, Sobkiewicz S, Wojt M, et al. Sperm DNA fragmentation index and hyaluronan binding ability in men from infertile couples and men with testicular germ cell tumor. Biomed Res Int 2016;2016:7893961
Kumar K, Lewis S, Vinci S, Riera-Escamilla A, Fino MG, Tamburrino L, et al. Evaluation of sperm DNA quality in men presenting with testicular cancer and lymphoma using alkaline and neutral Comet assays. Andrology 2018;6:230–235.
Said TM, Tellez S, Evenson DP, Del Valle AP. Assessment of sperm quality, DNA integrity and cryopreservation protocols in men diagnosed with testicular and systemic malignancies. Andrologia 2009;41:377–382.
Fariello RM, Pariz JR, Spaine DM, Cedenho AP, Bertolla RP, Fraietta R. Association between obesity and alteration of sperm DNA integrity and mitochondrial activity. BJU Int 2012;110:863–867.
Yang Q, Zhao F, Hu L, Bai R, Zhang N, Yao G, et al. Effect of paternal overweight or obesity on IVF treatment outcomes and the possible mechanisms involved. Sci Rep 2016;6:29787
Pearce KL, Hill A, Tremellen KP. Obesity related metabolic endotoxemia is associated with oxidative stress and impaired sperm DNA integrity. Basic Clin Androl 2019;29:6
Dupont C, Faure C, Sermondade N, Boubaya M, Eustache F, Clément P, et al. Obesity leads to higher risk of sperm DNA damage in infertile patients. Asian J Androl 2013;15:622–625.
Mir J, Franken D, Andrabi SW, Ashraf M, Rao K. Impact of weight loss on sperm DNA integrity in obese men. Andrologia. 2018 [doi: 10.1111/and.12957]
[Epub].
Agbaje IM, Rogers DA, McVicar CM, McClure N, Atkinson AB, Mallidis C, et al. Insulin dependant diabetes mellitus: implications for male reproductive function. Hum Reprod 2007;22:1871–1877.
Karimi J, Goodarzi MT, Tavilani H, Khodadadi I, Amiri I. Increased receptor for advanced glycation end products in spermatozoa of diabetic men and its association with sperm nuclear DNA fragmentation. Andrologia 2012;44 Suppl 1:280–286.
Levine RJ, Brown MH, Bell M, Shue F, Greenberg GN, Bordson BL. Air-conditioned environments do not prevent deterioration of human semen quality during the summer. Fertil Steril 1992;57:1075–1083.
Paul C, Murray AA, Spears N, Saunders PT. A single, mild, transient scrotal heat stress causes DNA damage, subfertility and impairs formation of blastocysts in mice. Reproduction 2008;136:73–84.
Zhang MH, Shi ZD, Yu JC, Zhang YP, Wang LG, Qiu Y. Scrotal heat stress causes sperm chromatin damage and cysteinyl aspartate-spicific proteinases 3 changes in fertile men. J Assist Reprod Genet 2015;32:747–755.
Hamilton TRDS, Siqueira AFP, de Castro LS, Mendes CM, Delgado JC, de Assis PM, et al. Effect of heat stress on sperm DNA: protamine assessment in ram spermatozoa and testicle. Oxid Med Cell Longev 2018;2018:5413056
Rockett JC, Mapp FL, Garges JB, Luft JC, Mori C, Dix DJ. Effects of hyperthermia on spermatogenesis, apoptosis, gene expression, and fertility in adult male mice. Biol Reprod 2001;65:229–239.
Shiraishi K, Takihara H, Matsuyama H. Elevated scrotal temperature, but not varicocele grade, reflects testicular oxidative stress-mediated apoptosis. World J Urol 2010;28:359–364.
Kanter M, Aktas C, Erboga M. Heat stress decreases testicular germ cell proliferation and increases apoptosis in short term: an immunohistochemical and ultrastructural study. Toxicol Ind Health 2013;29:99–113.
Sheynkin Y, Jung M, Yoo P, Schulsinger D, Komaroff E. Increase in scrotal temperature in laptop computer users. Hum Reprod 2005;20:452–455.
Mieusset R, Bujan L, Massat G, Mansat A, Pontonnier F. Clinical and biological characteristics of infertile men with a history of cryptorchidism. Hum Reprod 1995;10:613–619.
Bujan L, Daudin M, Charlet JP, Thonneau P, Mieusset R. Increase in scrotal temperature in car drivers. Hum Reprod 2000;15:1355–1357.
Selevan SG, Borkovec L, Slott VL, Zudová Z, Rubes J, Evenson DP, et al. Semen quality and reproductive health of young Czech men exposed to seasonal air pollution. Environ Health Perspect 2000;108:887–894.
Rubes J, Selevan SG, Evenson DP, Zudova D, Vozdova M, Zudova Z, et al. Episodic air pollution is associated with increased DNA fragmentation in human sperm without other changes in semen quality. Hum Reprod 2005;20:2776–2783.
Calogero AE, La Vignera S, Condorelli RA, Perdichizzi A, Valenti D, Asero P, et al. Environmental car exhaust pollution damages human sperm chromatin and DNA. J Endocrinol Invest 2011;34:e139–e143.
De Rosa M, Zarrilli S, Paesano L, Carbone U, Boggia B, Petretta M, et al. Traffic pollutants affect fertility in men. Hum Reprod 2003;18:1055–1061.
Hansen C, Luben TJ, Sacks JD, Olshan A, Jeffay S, Strader L, et al. The effect of ambient air pollution on sperm quality. Environ Health Perspect 2010;118:203–209.
Radwan M, Jurewicz J, Polańska K, Sobala W, Radwan P, Bochenek M, et al. Exposure to ambient air pollution: Does it affect semen quality and the level of reproductive hormones? Ann Hum Biol 2016;43:50–56.
Xu DX, Shen HM, Zhu QX, Chua L, Wang QN, Chia SE, et al. The associations among semen quality, oxidative DNA damage in human spermatozoa and concentrations of cadmium, lead and selenium in seminal plasma. Mutat Res 2003;534:155–163.
Hsu PC, Chang HY, Guo YL, Liu YC, Shih TS. Effect of smoking on blood lead levels in workers and role of reactive oxygen species in lead-induced sperm chromatin DNA damage. Fertil Steril 2009;91:1096–1103.
Bian Q, Xu LC, Wang SL, Xia YK, Tan LF, Chen JF, et al. Study on the relation between occupational fenvalerate exposure and spermatozoa DNA damage of pesticide factory workers. Occup Environ Med 2004;61:999–1005.
Sánchez-Peña LC, Reyes BE, López-Carrillo L, Recio R, Morán-Martínez J, Cebrián ME, et al. Organophosphorous pesticide exposure alters sperm chromatin structure in Mexican agricultural workers. Toxicol Appl Pharmacol 2004;196:108–113.
Wijesekara GU, Fernando DM, Wijerathna S, Bandara N. Environmental and occupational exposures as a cause of male infertility. Ceylon Med J 2015;60:52–56.
Migliore L, Naccarati A, Zanello A, Scarpato R, Bramanti L, Mariani M. Assessment of sperm DNA integrity in workers exposed to styrene. Hum Reprod 2002;17:2912–2918.
Meeker JD, Ehrlich S, Toth TL, Wright DL, Calafat AM, Trisini AT, et al. Semen quality and sperm DNA damage in relation to urinary bisphenol A among men from an infertility clinic. Reprod Toxicol 2010;30:532–539.
Wu DH, Leung YK, Thomas MA, Maxwell R, Ho SM. Bisphenol A (BPA) confers direct genotoxicity to sperm with increased sperm DNA fragmentation. Fertil Steril 2011;96:S5–S6.
Rahman MS, Kwon WS, Lee JS, Yoon SJ, Ryu BY, Pang MG. Bisphenol-A affects male fertility via fertility-related proteins in spermatozoa. Sci Rep 2015;5:9169
Sun JG, Jurisicova A, Casper RF. Detection of deoxyribonucleic acid fragmentation in human sperm: correlation with fertilization in vitro. Biol Reprod 1997;56:602–607.
Künzle R, Mueller MD, Hänggi W, Birkhäuser MH, Drescher H, Bersinger NA. Semen quality of male smokers and nonsmokers in infertile couples. Fertil Steril 2003;79:287–291.
Calogero A, Polosa R, Perdichizzi A, Guarino F, La Vignera S, Scarfia A, et al. Cigarette smoke extract immobilizes human spermatozoa and induces sperm apoptosis. Reprod Biomed Online 2009;19:564–571.
Sharma R, Harlev A, Agarwal A, Esteves SC. Cigarette smoking and semen quality: a new meta-analysis examining the effect of the 2010 World Health Organization laboratory methods for the examination of human semen. Eur Urol 2016;70:635–645.
Saleh RA, Agarwal A, Sharma RK, Nelson DR, Thomas AJ Jr. Effect of cigarette smoking on levels of seminal oxidative stress in infertile men: a prospective study. Fertil Steril 2002;78:491–499.
Oyeyipo IP, Maartens PJ, du Plessis SS. In vitro effects of nicotine on human spermatozoa. Andrologia 2014;46:887–892.
Oliveira H, Spanò M, Santos C, Pereira Mde L. Adverse effects of cadmium exposure on mouse sperm. Reprod Toxicol 2009;28:550–555.
Pant N, Kumar G, Upadhyay AD, Patel DK, Gupta YK, Chaturvedi PK. Reproductive toxicity of lead, cadmium, and phthalate exposure in men. Environ Sci Pollut Res Int 2014;21:11066–11074.
Perrin J, Tassistro V, Mandon M, Grillo JM, Botta A, Sari-Minodier I. Tobacco consumption and benzo(a)pyrene-diolepoxide-DNA adducts in spermatozoa: in smokers, swim-up procedure selects spermatozoa with decreased DNA damage. Fertil Steril 2011;95:2013–2017.
Talebi AR, Sarcheshmeh AA, Khalili MA, Tabibnejad N. Effects of ethanol consumption on chromatin condensation and DNA integrity of epididymal spermatozoa in rat. Alcohol 2011;45:403–409.
Akang EN, Oremosu AA, Osinubi AA, James AB, Biose IJ, Dike SI, et al. Alcohol-induced male infertility: Is sperm DNA fragmentation a causative? J Exp Clin Anat 2017;16:53–59.
Aboulmaouahib S, Madkour A, Kaarouch I, Sefrioui O, Saadani B, Copin H, et al. Impact of alcohol and cigarette smoking consumption in male fertility potential: looks at lipid peroxidation, enzymatic antioxidant activities and sperm DNA damage. Andrologia. 2018 [doi: 10.1111/and.12926]
Agarwal A, Desai NR, Makker K, Varghese A, Mouradi R, Sabanegh E, et al. Effects of radiofrequency electromagnetic waves (RF-EMW) from cellular phones on human ejaculated semen: an in vitro pilot study. Fertil Steril 2009;92:1318–1325.
Desai NR, Kesari KK, Agarwal A. Pathophysiology of cell phone radiation: oxidative stress and carcinogenesis with focus on male reproductive system. Reprod Biol Endocrinol 2009;7:114
De Iuliis GN, Newey RJ, King BV, Aitken RJ. Mobile phone radiation induces reactive oxygen species production and DNA damage in human spermatozoa in vitro. PLoS One 2009;4:e6446
Chatterjee R, Haines GA, Perera DM, Goldstone A, Morris ID. Testicular and sperm DNA damage after treatment with fludarabine for chronic lymphocytic leukaemia. Hum Reprod 2000;15:762–766.
Mathur PP, Saradha B, Vaithinathan S. Impact of environmental toxicants on testicular function. Immunol Endocr Metab Agents Med Chem 2008;8:79–90.
Agarwal A, Makker K, Sharma R. Clinical relevance of oxidative stress in male factor infertility: an update. Am J Reprod Immunol 2008;59:2–11.
Aitken RJ, Gibb Z, Baker MA, Drevet J, Gharagozloo P. Causes and consequences of oxidative stress in spermatozoa. Reprod Fertil Dev 2016;28:1–10.
Pourmasumi S, Sabeti P, Rahiminia T, Mangoli E, Tabibnejad N, Talebi AR. The etiologies of DNA abnormalities in male infertility: an assessment and review. Int J Reprod Biomed (Yazd) 2017;15:331–344.
Santi D, Spaggiari G, Simoni M. Sperm DNA fragmentation index as a promising predictive tool for male infertility diagnosis and treatment management - meta-analyses. Reprod Biomed Online 2018;37:315–326.
Bauer NC, Corbett AH, Doetsch PW. The current state of eukaryotic DNA base damage and repair. Nucleic Acids Res 2015;43:10083–10101.
Hakem R. DNA-damage repair; the good, the bad, and the ugly. EMBO J 2008;27:589–605.
Gosálvez J, López-Fernández C, Fernández JL, Esteves SC, Johnston SD. Unpacking the mysteries of sperm DNA fragmentation: ten frequently asked questions. J Reprod Biotechnol Fertil 2015;4:1–16.
Kowalczykowski SC. Initiation of genetic recombination and recombination-dependent replication. Trends Biochem Sci 2000;25:156–165.
Cox MM, Goodman MF, Kreuzer KN, Sherratt DJ, Sandler SJ, Marians KJ. The importance of repairing stalled replication forks. Nature 2000;404:37–41.
Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature 2009;461:1071–1078.
Valdiglesias V, Giunta S, Fenech M, Neri M, Bonassi S. γH2AX as a marker of DNA double strand breaks and genomic instability in human population studies. Mutat Res 2013;753:24–40.
Ribas-Maynou J, García-Peiró A, Fernandez-Encinas A, Amengual MJ, Prada E, Cortés P, et al. Double stranded sperm DNA breaks, measured by Comet assay, are associated with unexplained recurrent miscarriage in couples without a female factor. PLoS One 2012;7:e44679
Casanovas A, Ribas-Maynou J, Lara-Cerrillo S, Jimenez-Macedo AR, Hortal O, Benet J, et al. Double-stranded sperm DNA damage is a cause of delay in embryo development and can impair implantation rates. Fertil Steril 2019;111:699–707.e1.
Ribas-Maynou J, Benet J. Single and double strand sperm DNA damage: different reproductive effects on male fertility. Genes (Basel) 2019;10:105
Garolla A, Cosci I, Bertoldo A, Sartini B, Boudjema E, Foresta C. DNA double strand breaks in human spermatozoa can be predictive for assisted reproductive outcome. Reprod Biomed Online 2015;31:100–107.
Simon L, Aston KI, Emery BR, Hotaling J, Carrell DT. Sperm DNA damage output parameters measured by the alkaline Comet assay and their importance. Andrologia. 2017 [doi: 10.1111/and.12608]
Cortés-Gutiérrez EI, Fernández JL, Dávila-Rodríguez MI, López-Fernández C, Gosálvez J. Two-tailed comet assay (2T-comet): simultaneous detection of DNA single and double strand breaks. Methods Mol Biol 2017;1560:285–293.
Mah LJ, El-Osta A, Karagiannis TC. gammaH2AX: a sensitive molecular marker of DNA damage and repair. Leukemia 2010;24:679–686.
Sharma RK, Sabanegh E, Mahfouz R, Gupta S, Thiyagarajan A, Agarwal A. TUNEL as a test for sperm DNA damage in the evaluation of male infertility. Urology 2010;76:1380–1386.
Fernández JL, Muriel L, Rivero MT, Goyanes V, Vazquez R, Alvarez JG. The sperm chromatin dispersion test: a simple method for the determination of sperm DNA fragmentation. J Androl 2003;24:59–66.
Evenson DP. Sperm chromatin structure assay (SCSA®). Methods Mol Biol 2013;927:147–164.
Jiang H, He RB, Wang CL, Zhu J. The relationship of sperm DNA fragmentation index with the outcomes of in-vitro fertilisation-embryo transfer and intracytoplasmic sperm injection. J Obstet Gynaecol 2011;31:636–639.
Zhang Z, Zhu LL, Jiang HS, Chen H, Chen Y, Dai YT. Predictors of pregnancy outcome for infertile couples attending IVF and ICSI programmes. Andrologia 2016;48:874–881.
Nuñez-Calonge R, Caballero P, López-Fernández C, Guijarro JA, Fernández JL, Johnston S, et al. An improved experimental model for understanding the impact of sperm DNA fragmentation on human pregnancy following ICSI. Reprod Sci 2012;19:1163–1168.
Gosálvez J, Caballero P, López-Fernández C, Ortega L, Guijarro JA, Fernández JL, et al. Can DNA fragmentation of neat or swim-up spermatozoa be used to predict pregnancy following ICSI of fertile oocyte donors? Asian J Androl 2013;15:812–818.
López G, Lafuente R, Checa MA, Carreras R, Brassesco M. Diagnostic value of sperm DNA fragmentation and sperm high-magnification for predicting outcome of assisted reproduction treatment. Asian J Androl 2013;15:790–794.
Jin J, Pan C, Fei Q, Ni W, Yang X, Zhang L, et al. Effect of sperm DNA fragmentation on the clinical outcomes for in vitro fertilization and intracytoplasmic sperm injection in women with different ovarian reserves. Fertil Steril 2015;103:910–916.
Ribeiro S, Sharma R, Gupta S, Cakar Z, De Geyter C, Agarwal A. Inter- and intra-laboratory standardization of TUNEL assay for assessment of sperm DNA fragmentation. Andrology 2017;5:477–485.
Mahfouz RZ, du Plessis SS, Aziz N, Sharma R, Sabanegh E, Agarwal A. Sperm viability, apoptosis, and intracellular reactive oxygen species levels in human spermatozoa before and after induction of oxidative stress. Fertil Steril 2010;93:814–821.
Homa ST, Vassiliou AM, Stone J, Killeen AP, Dawkins A, Xie J, et al. A comparison between two assays for measuring seminal oxidative stress and their relationship with sperm DNA fragmentation and semen parameters. Genes (Basel) 2019;10:236
Henkel R, Kierspel E, Stalf T, Mehnert C, Menkveld R, Tinneberg HR, et al. Effect of reactive oxygen species produced by spermatozoa and leukocytes on sperm functions in nonleukocytospermic patients. Fertil Steril 2005;83:635–642.
Mahfouz R, Sharma R, Sharma D, Sabanegh E, Agarwal A. Diagnostic value of the total antioxidant capacity (TAC) in human seminal plasma. Fertil Steril 2009;91:805–811.
Khosravi F, Valojerdi MR, Amanlou M, Karimian L, Abolhassani F. Relationship of seminal reactive nitrogen and oxygen species and total antioxidant capacity with sperm DNA fragmentation in infertile couples with normal and abnormal sperm parameters. Andrologia 2014;46:17–23.
Kamkar N, Ramezanali F, Sabbaghian M. The relationship between sperm DNA fragmentation, free radicals and antioxidant capacity with idiopathic repeated pregnancy loss. Reprod Biol 2018;18:330–335.
Morris A, Siebert I, Agarwal A, Henkel R. Prediction of successful ICSI cycles by oxidation-reduction potential (ORP) and sperm DNA fragmentation (SDF) analysis; Paper presented at: the 35th Annual Meeting of the European Society of Human Reproduction and Embryology; 2019 Jun 23–26; Vienna, Austria.
Majzoub A, Arafa M, Mahdi M, Agarwal A, Al Said S, Al-Emadi I, et al. Oxidation-reduction potential and sperm DNA fragmentation, and their associations with sperm morphological anomalies amongst fertile and infertile men. Arab J Urol 2018;16:87–95.
Arafa M, Henkel R, Agarwal A, Majzoub A, Elbardisi H. Correlation of oxidation-reduction potential with hormones, semen parameters and testicular volume. Andrologia 2019;51:e13258
De Iuliis GN, Thomson LK, Mitchell LA, Finnie JM, Koppers AJ, Hedges A, et al. DNA damage in human spermatozoa is highly correlated with the efficiency of chromatin remodeling and the formation of 8-hydroxy-2′-deoxyguanosine, a marker of oxidative stress. Biol Reprod 2009;81:517–524.
McPherson SM, Longo FJ. Localization of DNase I-hypersensitive regions during rat spermatogenesis: stage-dependent patterns and unique sensitivity of elongating spermatids. Mol Reprod Dev 1992;31:268–279.
Aoki VW, Liu L, Carrell DT. Identification and evaluation of a novel sperm protamine abnormality in a population of infertile males. Hum Reprod 2005;20:1298–1306.
Agarwal A, Cho CL, Majzoub A, Esteves SC. The Society for Translational Medicine: clinical practice guidelines for sperm DNA fragmentation testing in male infertility. Transl Androl Urol 2017;6 Suppl 4:S720–S733.
Zini A. Are sperm chromatin and DNA defects relevant in the clinic? Syst Biol Reprod Med 2011;57:78–85.
Borges E Jr, Zanetti BF, Setti AS, Braga DPAF, Provenza RR, Iaconelli A Jr. Sperm DNA fragmentation is correlated with poor embryo development, lower implantation rate, and higher miscarriage rate in reproductive cycles of non-male factor infertility. Fertil Steril 2019;112:483–490.
Ruvolo G, Fattouh RR, Bosco L, Brucculeri AM, Cittadini E. New molecular markers for the evaluation of gamete quality. J Assist Reprod Genet 2013;30:207–212.
Spanò M, Bonde JP, Hjøllund HI, Kolstad HA, Cordelli E, Leter G. Sperm chromatin damage impairs human fertility. The Danish First Pregnancy Planner Study Team. Fertil Steril 2000;73:43–50.
Chen Q, Zhao JY, Xue X, Zhu GX. The association between sperm DNA fragmentation and reproductive outcomes following intrauterine insemination, a meta analysis. Reprod Toxicol 2019;86:50–55.
Sugihara A, Van Avermaete F, Roelant E, Punjabi U, De Neubourg D. The role of sperm DNA fragmentation testing in predicting intra-uterine insemination outcome: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2020;244:8–15.
Li Z, Wang L, Cai J, Huang H. Correlation of sperm DNA damage with IVF and ICSI outcomes: a systematic review and meta-analysis. J Assist Reprod Genet 2006;23:367–376.
Zini A, Boman JM, Belzile E, Ciampi A. Sperm DNA damage is associated with an increased risk of pregnancy loss after IVF and ICSI: systematic review and meta-analysis. Hum Reprod 2008;23:2663–2668.
Zhao J, Zhang Q, Wang Y, Li Y. Whether sperm deoxyribonucleic acid fragmentation has an effect on pregnancy and miscarriage after in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis. Fertil Steril 2014;102:998–1005.e8.
Cissen M, Wely MV, Scholten I, Mansell S, Bruin JP, Mol BW, et al. Measuring sperm DNA fragmentation and clinical outcomes of medically assisted reproduction: a systematic review and meta-analysis. PLoS One 2016;11:e0165125
Collins JA, Barnhart KT, Schlegel PN. Do sperm DNA integrity tests predict pregnancy with in vitro fertilization? Fertil Steril 2008;89:823–831.
Simon L, Zini A, Dyachenko A, Ciampi A, Carrell DT. A systematic review and meta-analysis to determine the effect of sperm DNA damage on in vitro fertilization and intracytoplasmic sperm injection outcome. Asian J Androl 2017;19:80–90.
Osman A, Alsomait H, Seshadri S, El-Toukhy T, Khalaf Y. The effect of sperm DNA fragmentation on live birth rate after IVF or ICSI: a systematic review and meta-analysis. Reprod Biomed Online 2015;30:120–127.
Green KA, Patounakis G, Dougherty MP, Werner MD, Scott RT Jr, Franasiak JM. Sperm DNA fragmentation on the day of fertilization is not associated with embryologic or clinical outcomes after IVF/ICSI. J Assist Reprod Genet 2020;37:71–76.
Uppangala S, Pudakalakatti S, D'souza F, Salian SR, Kalthur G, Kumar P, et al. Influence of sperm DNA damage on human preimplantation embryo metabolism. Reprod Biol 2016;16:234–241.
Huang CC, Lin DP, Tsao HM, Cheng TC, Liu CH, Lee MS. Sperm DNA fragmentation negatively correlates with velocity and fertilization rates but might not affect pregnancy rates. Fertil Steril 2005;84:130–140.
Boe-Hansen GB, Fedder J, Ersbøll AK, Christensen P. The sperm chromatin structure assay as a diagnostic tool in the human fertility clinic. Hum Reprod 2006;21:1576–1582.
Nasr-Esfahani MH, Salehi M, Razavi S, Anjomshoa M, Rozbahani S, Moulavi F, et al. Effect of sperm DNA damage and sperm protamine deficiency on fertilization and embryo development post-ICSI. Reprod Biomed Online 2005;11:198–205.
Simon L, Proutski I, Stevenson M, Jennings D, McManus J, Lutton D, et al. Sperm DNA damage has a negative association with live-birth rates after IVF. Reprod Biomed Online 2013;26:68–78.
Gorelick JI, Goldstein M. Loss of fertility in men with varicocele. Fertil Steril 1993;59:613–616.
Practice Committee of the American Society for Reproductive Medicine; Society for Male Reproduction and Urology. Report on varicocele and infertility: a committee opinion. Fertil Steril 2014;102:1556–1560.
Kim KH, Lee JY, Kang DH, Lee H, Seo JT, Cho KS. Impact of surgical varicocele repair on pregnancy rate in subfertile men with clinical varicocele and impaired semen quality: a meta-analysis of randomized clinical trials. Korean J Urol 2013;54:703–709.
Zini A, Dohle G. Are varicoceles associated with increased deoxyribonucleic acid fragmentation? Fertil Steril 2011;96:1283–1287.
Blumer CG, Fariello RM, Restelli AE, Spaine DM, Bertolla RP, Cedenho AP. Sperm nuclear DNA fragmentation and mitochondrial activity in men with varicocele. Fertil Steril 2008;90:1716–1722.
Tanaka T, Kobori Y, Terai K, Inoue Y, Osaka A, Yoshikawa N, et al. Seminal oxidation-reduction potential and sperm DNA fragmentation index increase among infertile men with varicocele. Hum Fertil (Camb). 2020 [doi: 10.1080/14647273.2020.1712747]
[Epub].
Dieamant F, Petersen CG, Mauri AL, Conmar V, Mattila M, Vagnini LD, et al. Semen parameters in men with varicocele: DNA fragmentation, chromatin packaging, mitochondrial membrane potential, and apoptosis. JBRA Assist Reprod 2017;21:295–301.
Moazzam A, Sharma R, Agarwal A. Relationship of spermatozoal DNA fragmentation with semen quality in varicocelepositive men. Andrologia 2015;47:935–944.
Bertolla RP, Cedenho AP, Hassun Filho PA, Lima SB, Ortiz V, Srougi M. Sperm nuclear DNA fragmentation in adolescents with varicocele. Fertility and Sterility 2006;85:625–628.
Vivas-Acevedo G, Lozano-Hernández R, Camejo MI. Varicocele decreases epididymal neutral α-glucosidase and is associated with alteration of nuclear DNA and plasma membrane in spermatozoa. BJU Int 2014;113:642–649.
Bahreinian M, Tavalaee M, Abbasi H, Kiani-Esfahani A, Shiravi AH, Nasr-Esfahani MH. DNA hypomethylation predisposes sperm to DNA damage in individuals with varicocele. Syst Biol Reprod Med 2015;61:179–186.
Wang YJ, Zhang RQ, Lin YJ, Zhang RG, Zhang WL. Relationship between varicocele and sperm DNA damage and the effect of varicocele repair: a meta-analysis. Reprod Biomed Online 2012;25:307–314.
Roque M, Esteves SC. Effect of varicocele repair on sperm DNA fragmentation: a review. Int Urol Nephrol 2018;50:583–603.
Smit M, Romijn JC, Wildhagen MF, Veldhoven JL, Weber RF, Dohle GR. Decreased sperm DNA fragmentation after surgical varicocelectomy is associated with increased pregnancy rate. J Urol 2013;189 1 Suppl:S146–S150.
Ni K, Steger K, Yang H, Wang H, Hu K, Chen B. Sperm protamine mRNA ratio and DNA fragmentation index represent reliable clinical biomarkers for men with varicocele after microsurgical varicocele ligation. J Urol 2014;192:170–176.
Khadem N, Poorhoseyni A, Jalali M, Akbary A, Heydari ST. Sperm DNA fragmentation in couples with unexplained recurrent spontaneous abortions. Andrologia 2014;46:126–130.
Bareh GM, Jacoby E, Binkley P, Chang TC, Schenken RS, Robinson RD. Sperm deoxyribonucleic acid fragmentation assessment in normozoospermic male partners of couples with unexplained recurrent pregnancy loss: a prospective study. Fertil Steril 2016;105:329–336.e1.
Kumar K, Deka D, Singh A, Mitra DK, Vanitha BR, Dada R. Predictive value of DNA integrity analysis in idiopathic recurrent pregnancy loss following spontaneous conception. J Assist Reprod Genet 2012;29:861–867.
Halim B, Lubis HP. The association between sperm DNA fragmentation and idiopathic early recurrent pregnancy loss; Paper presented at: the 6th Congress of the Asia Pacific Initiative on Reproduction; 2016 Apr 8–10; Jakarta, Indonesia. pp. 55-63.
Tan J, Taskin O, Albert A, Bedaiwy MA. Association between sperm DNA fragmentation and idiopathic recurrent pregnancy loss: a systematic review and meta-analysis. Reprod Biomed Online 2019;38:951–960.
Oleszczuk K, Augustinsson L, Bayat N, Giwercman A, Bungum M. Prevalence of high DNA fragmentation index in male partners of unexplained infertile couples. Andrology 2013;1:357–360.
Le MT, Nguyen TAT, Nguyen HTT, Nguyen TTT, Nguyen VT, Le DD, et al. Does sperm DNA fragmentation correlate with semen parameters? Reprod Med Biol 2019;18:390–396.
Ganzer LM, Sad Larcher JM, Avramovich VI, Tissera AD, Estofan GM. Relationship between semen parameters and sperm DNA fragmentation. Fertil Steril 2017;108:e137–e138.
Saleh RA, Agarwal A, Nada EA, El-Tonsy MH, Sharma RK, Meyer A, et al. Negative effects of increased sperm DNA damage in relation to seminal oxidative stress in men with idiopathic and male factor infertility. Fertil Steril 2003;79 Suppl 3:1597–1605.
Pacey AA. Environmental and lifestyle factors associated with sperm DNA damage. Hum Fertil (Camb) 2010;13:189–193.
Komiya A, Kato T, Kawauchi Y, Watanabe A, Fuse H. Clinical factors associated with sperm DNA fragmentation in male patients with infertility. ScientificWorldJournal 2014;2014:868303
Ranganathan P, Rao KA, Thalaivarasai Balasundaram S. Deterioration of semen quality and sperm-DNA integrity as influenced by cigarette smoking in fertile and infertile human male smokers-A prospective study. J Cell Biochem 2019;120:11784–11793.
Lu JC, Jing J, Chen L, Ge YF, Feng RX, Liang YJ, et al. Analysis of human sperm DNA fragmentation index (DFI) related factors: a report of 1010 subfertile men in China. Reprod Biol Endocrinol 2018;16:23
Zhou DD, Hao JL, Guo KM, Lu CW, Liu XD. Sperm quality and DNA damage in men from Jilin Province, China, who are occupationally exposed to ionizing radiation. Genet Mol Res 2016;15:gmr8078
Boeri L, Capogrosso P, Ventimiglia E, Pozzi E, Chierigo F, Belladelli F, et al. Undiagnosed prediabetes status is associated with a reduced effectiveness of phosphodiesterase type 5 inhibitors in men with erectile dysfunction. Int J Impot Res 2020;32:393–400.
Antoniassi MP, Intasqui P, Camargo M, Zylbersztejn DS, Carvalho VM, Cardozo KH, et al. Analysis of the functional aspects and seminal plasma proteomic profile of sperm from smokers. BJU Int 2016;118:814–822.
Condorelli RA, La Vignera S, Mongioì LM, Alamo A, Calogero AE. Diabetes mellitus and infertility: different pathophysiological effects in type 1 and type 2 on sperm function. Front Endocrinol (Lausanne) 2018;9:268
Jurewicz J, Radwan M, Sobala W, Radwan P, Bochenek M, Hanke W. Dietary patterns and their relationship with semen quality. Am J Mens Health 2018;12:575–583.
Zhang MH, Zhai LP, Fang ZY, Li AN, Qiu Y, Liu YX. Impact of a mild scrotal heating on sperm chromosomal abnormality, acrosin activity and seminal alpha-glucosidase in human fertile males. Andrologia. 2018 [doi: 10.1111/and.12985]
[Epub].
Oliveira JBA, Petersen CG, Mauri AL, Vagnini LD, Renzi A, Petersen B, et al. Association between body mass index and sperm quality and sperm DNA integrity. A large population study. Andrologia. 2018 [doi: 10.1111/and.12889]
Dehghan Marvast L, Talebi AR, Ghasemzadeh J, Hosseini A, Pacey AA. Effects of Chlamydia trachomatis infection on sperm chromatin condensation and DNA integrity. Andrologia. 2018 [doi: 10.1111/and.12918]
Kumar D, Salian SR, Kalthur G, Uppangala S, Kumari S, Challapalli S, et al. Association between sperm DNA integrity and seminal plasma antioxidant levels in health workers occupationally exposed to ionizing radiation. Environ Res 2014;132:297–304.
Stenqvist A, Oleszczuk K, Leijonhufvud I, Giwercman A. Impact of antioxidant treatment on DNA fragmentation index: a double-blind placebo-controlled randomized trial. Andrology 2018;6:811–816.
Showell MG, Mackenzie-Proctor R, Brown J, Yazdani A, Stankiewicz MT, Hart RJ. Antioxidants for male subfertility. Cochrane Database Syst Rev 2014;(12):CD007411
Amar E, Cornet D, Cohen M, Ménézo Y. Treatment for high levels of sperm DNA fragmentation and nuclear decondensation: sequential treatment with a potent antioxidant followed by stimulation of the one-carbon cycle vs one-carbon cycle back-up alone. Austin J Reprod Med Infertil 2015;2:1006
Ménézo YJ, Hazout A, Panteix G, Robert F, Rollet J, Cohen-Bacrie P, et al. Antioxidants to reduce sperm DNA fragmenta-tion: an unexpected adverse effect. Reprod Biomed Online 2007;14:418–421.
Micic S, Lalic N, Djordjevic D, Bojanic N, Bogavac-Stanojevic N, Busetto GM, et al. Double-blind, randomised, placebocontrolled trial on the effect of L-carnitine and L-acetylcarnitine on sperm parameters in men with idiopathic oligoasthenozoospermia. Andrologia 2019;51:e13267
Tunc O, Thompson J, Tremellen K. Improvement in sperm DNA quality using an oral antioxidant therapy. Reprod Biomed Online 2009;18:761–768.
Greco E, Iacobelli M, Rienzi L, Ubaldi F, Ferrero S, Tesarik J. Reduction of the incidence of sperm DNA fragmentation by oral antioxidant treatment. J Androl 2005;26:349–353.
Henkel R, Sandhu IS, Agarwal A. The excessive use of antioxidant therapy: a possible cause of male infertility? Andrologia 2019;51:e13162
Schisterman EF, Sjaarda LA, Clemons T, Carrell DT, Perkins NJ, Johnstone E, et al. Effect of folic acid and zinc supplementation in men on semen quality and live birth among couples undergoing infertility treatment: a randomized clinical trial. JAMA 2020;323:35–48.
La Vignera S, Vicari E, Condorelli R, D'Agata R, Calogero AE. Hypertrophic-congestive and fibro-sclerotic ultrasound variants of male accessory gland infection have different sperm output. J Endocrinol Invest 2011;34:e330–e335.
Pasqualotto FF, Sharma RK, Potts JM, Nelson DR, Thomas AJ, Agarwal A. Seminal oxidative stress in patients with chronic prostatitis. Urology 2000;55:881–885.
Aitken RJ, De Iuliis GN. Origins and consequences of DNA damage in male germ cells. Reprod Biomed Online 2007;14:727–733.
Hamada A, Agarwal A, Sharma R, French DB, Ragheb A, Sabanegh ES Jr. Empirical treatment of low-level leukocytospermia with doxycycline in male infertility patients. Urology 2011;78:1320–1325.
Mostafa RM, Nasrallah YS, Hassan MM, Farrag AF, Majzoub A, Agarwal A. The effect of cigarette smoking on human seminal parameters, sperm chromatin structure and condensation. Andrologia. 2018 [doi: 10.1111/and.12910]
Jamal F, Haque QS, Singh S, Rastogi SK. The influence of organophosphate and carbamate on sperm chromatin and reproductive hormones among pesticide sprayers. Toxicol Ind Health 2016;32:1527–1536.
Lafuente R, García-Blàquez N, Jacquemin B, Checa MA. Outdoor air pollution and sperm quality. Fertil Steril 2016;106:880–896.
Sepidarkish M, Maleki-Hajiagha A, Maroufizadeh S, Rezaeinejad M, Almasi-Hashiani A, Razavi M. The effect of body mass index on sperm DNA fragmentation: a systematic review and meta-analysis. Int J Obes (Lond) 2020;44:549–558.
Samavat J, Cantini G, Lotti F, Di Franco A, Tamburrino L, Degl'Innocenti S, et al. Massive weight loss obtained by bariatric surgery affects semen quality in morbid male obesity: a preliminary prospective double-armed study. Obes Surg 2018;28:69–76.
Carette C, Levy R, Eustache F, Baron G, Coupaye M, Msika S, et al. Changes in total sperm count after gastric bypass and sleeve gastrectomy: the BARIASPERM prospective study. Surg Obes Relat Dis 2019;15:1271–1279.
Faure C, Dupont C, Baraibar MA, Ladouce R, Cedrin-Durnerin I, Wolf JP, et al. In subfertile couple, abdominal fat loss in men is associated with improvement of sperm quality and pregnancy: a case-series. PLoS One 2014;9:e86300
Agarwal A, Gupta S, Du Plessis S, Sharma R, Esteves SC, Cirenza C, et al. Abstinence time and its impact on basic and advanced semen parameters. Urology 2016;94:102–110.
Mayorga-Torres BJ, Camargo M, Agarwal A, du Plessis SS, Cadavid ÁP, Cardona Maya WD. Influence of ejaculation frequency on seminal parameters. Reprod Biol Endocrinol 2015;13:47
Jurema MW, Vieira AD, Bankowski B, Petrella C, Zhao Y, Wallach E, et al. Effect of ejaculatory abstinence period on the pregnancy rate after intrauterine insemination. Fertil Steril 2005;84:678–681.
Marshburn PB, Alanis M, Matthews ML, Usadi R, Papadakis MH, Kullstam S, et al. A short period of ejaculatory abstinence before intrauterine insemination is associated with higher pregnancy rates. Fertil Steril 2010;93:286–288.
Bahadur G, Almossawi O, IIlahibuccus A, Al-Habib A, Okolo S. Factors leading to pregnancies in stimulated intrauterine insemination cycles and the use of consecutive ejaculations within a small clinic environment. J Obstet Gynaecol India 2016;66 Suppl 1:513–520.
Sánchez-Martín P, Sánchez-Martín F, González-Martínez M, Gosálvez J. Increased pregnancy after reduced male abstinence. Syst Biol Reprod Med 2013;59:256–260.
Muratori M, Maggi M, Spinelli S, Filimberti E, Forti G, Baldi E. Spontaneous DNA fragmentation in swim-up selected human spermatozoa during long term incubation. J Androl 2003;24:253–262.
Di Santo M, Tarozzi N, Nadalini M, Borini A. Human sperm cryopreservation: update on techniques, effect on DNA integrity, and implications for ART. Adv Urol 2012;2012:854837
Ahmed I, Abdelateef S, Laqqan M, Amor H, Abdel-Lah MA, Hammadeh ME. Influence of extended incubation time on human sperm chromatin condensation, sperm DNA strand breaks and their effect on fertilisation rate. Andrologia. 2018 [doi: 10.1111/and.12960]
[Epub].
Raad G, Lteif L, Lahoud R, Azoury J, Azoury J, Tanios J, et al. Cryopreservation media differentially affect sperm motility, morphology and DNA integrity. Andrology 2018;6:836–845.
Jayaraman V, Upadhya D, Narayan PK, Adiga SK. Sperm processing by swim-up and density gradient is effective in elimination of sperm with DNA damage. J Assist Reprod Genet 2012;29:557–563.
Volpes A, Sammartano F, Rizzari S, Gullo S, Marino A, Allegra A. The pellet swim-up is the best technique for sperm preparation during in vitro fertilization procedures. J Assist Reprod Genet 2016;33:765–770.
Vozdova M, Kasikova K, Oracova E, Prinosilova P, Rybar R, Horinova V, et al. The effect of the swim-up and hyaluronan-binding methods on the frequency of abnormal spermatozoa detected by FISH and SCSA in carriers of balanced chromosomal translocations. Hum Reprod 2012;27:930–937.
Oguz Y, Guler I, Erdem A, Mutlu MF, Gumuslu S, Oktem M, et al. The effect of swim-up and gradient sperm preparation techniques on deoxyribonucleic acid (DNA) fragmentation in subfertile patients. J Assist Reprod Genet 2018;35:1083–1089.
Zini A, Finelli A, Phang D, Jarvi K. Influence of semen processing technique on human sperm DNA integrity. Urology 2000;56:1081–1084.
Rawe VY, Boudri HU, Alvarez Sedó C, Carro M, Papier S, Nodar F. Healthy baby born after reduction of sperm DNA fragmentation using cell sorting before ICSI. Reprod Biomed Online 2010;20:320–323.
Lee TH, Liu CH, Shih YT, Tsao HM, Huang CC, Chen HH, et al. Magnetic-activated cell sorting for sperm preparation reduces spermatozoa with apoptotic markers and improves the acrosome reaction in couples with unexplained infertility. Hum Reprod 2010;25:839–846.
Gil M, Sar-Shalom V, Melendez Sivira Y, Carreras R, Checa MA. Sperm selection using magnetic activated cell sorting (MACS) in assisted reproduction: a systematic review and meta-analysis. J Assist Reprod Genet 2013;30:479–485.
Tavalaee M, Deemeh MR, Arbabian M, Nasr-Esfahani MH. Density gradient centrifugation before or after magnetic-activated cell sorting: Which technique is more useful for clinical sperm selection? J Assist Reprod Genet 2012;29:31–38.
Delbes G, Herrero MB, Troeung ET, Chan PT. The use of complimentary assays to evaluate the enrichment of human sperm quality in asthenoteratozoospermic and teratozoospermic samples processed with Annexin-V magnetic activated cell sorting. Andrology 2013;1:698–706.
Bucar S, Gonçalves A, Rocha E, Barros A, Sousa M, Sá R. DNA fragmentation in human sperm after magnetic-activated cell sorting. J Assist Reprod Genet 2015;32:147–154.
Zhang H, Xuan X, Yang S, Li X, Xu C, Gao X. Selection of viable human spermatozoa with low levels of DNA fragmentation from an immotile population using density gradient centrifugation and magnetic-activated cell sorting. Andrologia. 2018 [doi: 10.1111/and.12821]
Franco JG Jr, Baruffi RL, Mauri AL, Petersen CG, Oliveira JB, Vagnini L. Significance of large nuclear vacuoles in human spermatozoa: implications for ICSI. Reprod Biomed Online 2008;17:42–45.
Garolla A, Fortini D, Menegazzo M, De Toni L, Nicoletti V, Moretti A, et al. High-power microscopy for selecting spermatozoa for ICSI by physiological status. Reprod Biomed Online 2008;17:610–616.
Quinn MM, Jalalian L, Ribeiro S, Ona K, Demirci U, Cedars MI, et al. Microfluidic sorting selects sperm for clinical use with reduced DNA damage compared to density gradient centrifugation with swim-up in split semen samples. Hum Reprod 2018;33:1388–1393.
Parmegiani L, Cognigni GE, Bernardi S, Troilo E, Ciampaglia W, Filicori M. "Physiologic ICSI": hyaluronic acid (HA) favors selection of spermatozoa without DNA fragmentation and with normal nucleus, resulting in improvement of embryo quality. Fertil Steril 2010;93:598–604.
Mongkolchaipak S, Vutyavanich T. No difference in highmagnification morphology and hyaluronic acid binding in the selection of euploid spermatozoa with intact DNA. Asian J Androl 2013;15:421–424.
Nosrati R, Vollmer M, Eamer L, San Gabriel MC, Zeidan K, Zini A, et al. Rapid selection of sperm with high DNA integrity. Lab Chip 2014;14:1142–1150.
Xie P, Keating D, Parrella A, Cheung S, Rosenwaks Z, Goldstein M, et al. Sperm genomic integrity by TUNEL varies throughout the male genital tract. J Urol 2020;203:802–808.
Moskovtsev SI, Jarvi K, Mullen JB, Cadesky KI, Hannam T, Lo KC. Testicular spermatozoa have statistically significantly lower DNA damage compared with ejaculated spermatozoa in patients with unsuccessful oral antioxidant treatment. Fertil Steril 2010;93:1142–1146.
Greco E, Scarselli F, Iacobelli M, Rienzi L, Ubaldi F, Ferrero S, et al. Efficient treatment of infertility due to sperm DNA damage by ICSI with testicular spermatozoa. Hum Reprod 2005;20:226–230.
Bradley CK, McArthur SJ, Gee AJ, Weiss KA, Schmidt U, Toogood L. Intervention improves assisted conception intracytoplasmic sperm injection outcomes for patients with high levels of sperm DNA fragmentation: a retrospective analysis. Andrology 2016;4:903–910.
Lopushnyan NA, Walsh TJ. Surgical techniques for the management of male infertility. Asian J Androl 2012;14:94–102.
Mehta A, Esteves SC, Schlegel PN, Niederberger CI, Sigman M, Zini A, et al. Use of testicular sperm in nonazoospermic males. Fertil Steril 2018;109:981–987.
Cheung S, Schlegel PN, Rosenwaks Z, Palermo GD. Revisiting aneuploidy profile of surgically retrieved spermatozoa by whole exome sequencing molecular karyotype. PLoS One 2019;14:e0210079
American Urological Association. The optimal evaluation of the infertile male: AUA best practice statement [Internet]. Linthicum (MD): American Urological Association; c2010 [cited 2020 May 1].
Practice Committee of the American Society for Reproductive Medicine. Diagnostic evaluation of the infertile male: a committee opinion. Fertil Steril 2015;103:e18–e25.
European Association of Urology. Male Infertility [Internet]. Arnhem: European Association of Urology; c2019 [cited 2020 May 1].
Smits RM, Mackenzie-Proctor R, Yazdani A, Stankiewicz MT, Jordan V, Showell MG. Antioxidants for male subfertility. Cochrane Database Syst Rev 2019;3:CD007411
Roque M, Bedoschi G, Esteves SC. Effect of varicocele repair on sperm DNA fragmentation: a systematic review and metaanalysis. Fertil Steril 2018;110:e162
Smit M, Romijn JC, Wildhagen MF, Veldhoven JL, Weber RF, Dohle GR. Decreased sperm DNA fragmentation after surgical varicocelectomy is associated with increased pregnancy rate. J Urol 2010;183:270–274.
Baker K, McGill J, Sharma R, Agarwal A, Sabanegh E Jr. Pregnancy after varicocelectomy: impact of postoperative motility and DFI. Urology 2013;81:760–766.
Mohammed EE, Mosad E, Zahran AM, Hameed DA, Taha EA, Mohamed MA. Acridine orange and flow cytometry: Which is better to measure the effect of varicocele on sperm DNA integrity? Adv Urol 2015;2015:814150
Krishna Reddy SV, Basha Shaik A, Sailaja S, Venkataramanaiah M. Outcome of varicocelectomy with different degrees of clinical varicocele in infertile male. Adv Androl 2015;2015:432950
Agarwal A, Cho CL, Esteves SC. Should we evaluate and treat sperm DNA fragmentation? Curr Opin Obstet Gynecol 2016;28:164–171.
Cho CL, Agarwal A. Role of sperm DNA fragmentation in male factor infertility: a systematic review. Arab J Urol 2017;16:21–34.
Zini A, Sigman M. Are tests of sperm DNA damage clinically useful? Pros and cons. J Androl 2009;30:219–229.
Arafa M, AlMalki A, AlBadr M, Burjaq H, Majzoub A, AlSaid S, et al. ICSI outcome in patients with high DNA fragmentation: testicular versus ejaculated spermatozoa. Andrologia. 2018 [doi: 10.1111/and.12835]
Herrero MB, Lusignan MF, Son WY, Sabbah M, Buckett W, Chan P. ICSI outcomes using testicular spermatozoa in nonazoospermic couples with recurrent ICSI failure and no previous live births. Andrology 2019;7:281–287.
Bernardini L, Gianaroli L, Fortini D, Conte N, Magli C, Cavani S, et al. Frequency of hyper-, hypohaploidy and diploidy in ejaculate, epididymal and testicular germ cells of infertile patients. Hum Reprod 2000;15:2165–2172.
Palermo GD, Colombero LT, Hariprashad JJ, Schlegel PN, Rosenwaks Z. Chromosome analysis of epididymal and testicular sperm in azoospermic patients undergoing ICSI. Hum Reprod 2002;17:570–575.
Malić Vončina S, Golob B, Ihan A, Kopitar AN, Kolbezen M, Zorn B. Sperm DNA fragmentation and mitochondrial membrane potential combined are better for predicting natural conception than standard sperm parameters. Fertil Steril 2016;105:637–644.e1.
Giwercman A, Lindstedt L, Larsson M, Bungum M, Spano M, Levine RJ, et al. Sperm chromatin structure assay as an independent predictor of fertility in vivo: a case-control study. Int J Androl 2010;33:e221–e227.
Loft S, Kold-Jensen T, Hjollund NH, Giwercman A, Gyllemborg J, Ernst E, et al. Oxidative DNA damage in human sperm influences time to pregnancy. Hum Reprod 2003;18:1265–1272.
Pelliccione F, d'Angeli A, Cinque B, Falone S, Micillo A, Francavilla F, et al. Activation of the immune system and sperm DNA fragmentation are associated with idiopathic oligoasthenoteratospermia in men with couple subfertility. Fertil Steril 2011;95:2676–2679.e1-3.
Zandieh Z, Vatannejad A, Doosti M, Zabihzadeh S, Haddadi M, Bajelan L, et al. Comparing reactive oxygen species and DNA fragmentation in semen samples of unexplained infertile and healthy fertile men. Ir J Med Sci 2018;187:657–662.
Aktan G, Doğru-Abbasoğlu S, Küçükgergin C, Kadıoğlu A, Ozdemirler-Erata G, Koçak-Toker N. Mystery of idiopathic male infertility: is oxidative stress an actual risk? Fertil Steril 2013;99:1211–1215.
Vandekerckhove FW, De Croo I, Gerris J, Vanden Abbeel E, De Sutter P. Sperm chromatin dispersion test before sperm preparation is predictive of clinical pregnancy in cases of unexplained infertility treated with intrauterine insemination and induction with clomiphene citrate. Front Med (Lausanne) 2016;3:63
Rybar R, Markova P, Veznik Z, Faldikova L, Kunetkova M, Zajicova A, et al. Sperm chromatin integrity in young men with no experiences of infertility and men from idiopathic infertility couples. Andrologia 2009;41:141–149.
Rahimizadeh P, Topraggaleh TR, Nasr-Esfahani MH, Ziarati N, Mirshahvaladi S, Esmaeili V, et al. The alteration of PLCζ protein expression in unexplained infertile and asthenoteratozoospermic patients: a potential effect on sperm fertilization ability. Mol Reprod Dev 2020;87:115–123.
O'Neill CL, Parrella A, Keating D, Cheung S, Rosenwaks Z, Palermo GD. A treatment algorithm for couples with unexplained infertility based on sperm chromatin assessment. J Assist Reprod Genet 2018;35:1911–1917.
Carrell DT, Liu L, Peterson CM, Jones KP, Hatasaka HH, Erickson L, et al. Sperm DNA fragmentation is increased in couples with unexplained recurrent pregnancy loss. Arch Androl 2003;49:49–55.
Bellver J, Meseguer M, Muriel L, García-Herrero S, Barreto MA, Garda AL, et al. Y chromosome microdeletions, sperm DNA fragmentation and sperm oxidative stress as causes of recurrent spontaneous abortion of unknown etiology. Hum Reprod 2010;25:1713–1721.
Absalan F, Ghannadi A, Kazerooni M, Parifar R, Jamalzadeh F, Amiri S. Value of sperm chromatin dispersion test in couples with unexplained recurrent abortion. J Assist Reprod Genet 2012;29:11–14.
Imam SN, Shamsi MB, Kumar K, Deka D, Dada R. Idiopathic recurrent pregnancy loss: role of paternal factors; a pilot study. J Reprod Infertil 2011;12:267–276.
Venkatesh S, Thilagavathi J, Kumar K, Deka D, Talwar P, Dada R. Cytogenetic, Y chromosome microdeletion, sperm chromatin and oxidative stress analysis in male partners of couples experiencing recurrent spontaneous abortions. Arch Gynecol Obstet 2011;284:1577–1584.
Leach M, Aitken RJ, Sacks G. Sperm DNA fragmentation abnormalities in men from couples with a history of recurrent miscarriage. Aust N Z J Obstet Gynaecol 2015;55:379–383.
Talebi AR, Vahidi S, Aflatoonian A, Ghasemi N, Ghasemzadeh J, Firoozabadi RD, et al. Cytochemical evaluation of sperm chromatin and DNA integrity in couples with unexplained recurrent spontaneous abortions. Andrologia 2012;44 Suppl 1:462–470.
Zhang L, Wang L, Zhang X, Xu G, Zhang W, Wang K, et al. Sperm chromatin integrity may predict future fertility for unexplained recurrent spontaneous abortion patients. Int J Androl 2012;35:752–757.
Thilagavathi J, Mishra SS, Kumar M, Vemprala K, Deka D, Dhadwal V, et al. Analysis of telomere length in couples experiencing idiopathic recurrent pregnancy loss. J Assist Reprod Genet 2013;30:793–798.
Ramasamy R, Scovell JM, Kovac JR, Cook PJ, Lamb DJ, Lipshultz LI. Fluorescence in situ hybridization detects increased sperm aneuploidy in men with recurrent pregnancy loss. Fertil Steril 2015;103:906–909.e1.
Zidi-Jrah I, Hajlaoui A, Mougou-Zerelli S, Kammoun M, Meniaoui I, Sallem A, et al. Relationship between sperm aneuploidy, sperm DNA integrity, chromatin packaging, traditional semen parameters, and recurrent pregnancy loss. Fertil Steril 2016;105:58–64.
Carlini T, Paoli D, Pelloni M, Faja F, Dal Lago A, Lombardo F, et al. Sperm DNA fragmentation in Italian couples with recurrent pregnancy loss. Reprod Biomed Online 2017;34:58–65.
Eisenberg ML, Sapra KJ, Kim SD, Chen Z, Buck Louis GM. Semen quality and pregnancy loss in a contemporary cohort of couples recruited before conception: data from the Longitudinal Investigation of Fertility and the Environment (LIFE) Study. Fertil Steril 2017;108:613–619.
Park YS, Lee SH, Choi HW, Lee HS, Lee JS, Seo JT. Abnormal human sperm parameters contribute to sperm DNA fragmentation in men with varicocele. World J Mens Health 2018;36:239–247.
Janghorban-Laricheh E, Ghazavi-Khorasgani N, Tavalaee M, Zohrabi D, Abbasi H, Nasr-Esfahani MH. An association between sperm PLCζ levels and varicocele? J Assist Reprod Genet 2016;33:1649–1655.
Cortés-Gutiérrez EI, Dávila-Rodríguez MI, Fernández JL, López-Fernández C, Aragón-Tovar AR, Urbina-Bernal LC, et al. DNA damage in spermatozoa from infertile men with varicocele evaluated by sperm chromatin dispersion and DBDFISH. Arch Gynecol Obstet 2016;293:189–196.
Blumer CG, Restelli AE, Giudice PT, Soler TB, Fraietta R, Nichi M, et al. Effect of varicocele on sperm function and semen oxidative stress. BJU Int 2012;109:259–265.
Saleh RA, Agarwal A, Sharma RK, Said TM, Sikka SC, Thomas AJ Jr. Evaluation of nuclear DNA damage in spermatozoa from infertile men with varicocele. Fertil Steril 2003;80:1431–1436.
Nguyen TT, Trieu TS, Tran TO, Luong TLA. Evaluation of sperm DNA fragmentation index, Zinc concentration and seminal parameters from infertile men with varicocele. Andrologia 2019;51:e13184
Tang K, Xue W, Xing Y, Xu S, Wu Q, Liu R, et al. Genetic polymorphisms of glutathione S-transferase M1, T1, and P1, and the assessment of oxidative damage in infertile men with varicoceles from northwestern China. J Androl 2012;33:257–263.
Smith R, Kaune H, Parodi D, Madariaga M, Rios R, Morales I, et al. Increased sperm DNA damage in patients with varicocele: relationship with seminal oxidative stress. Hum Reprod 2006;21:986–993.
Enciso M, Muriel L, Fernández JL, Goyanes V, Segrelles E, Marcos M, et al. Infertile men with varicocele show a high relative proportion of sperm cells with intense nuclear damage level, evidenced by the sperm chromatin dispersion test. J Androl 2006;27:106–111.
Zümrütbaş AE, Gülpınar Ö, Mermerkaya M, Süer E, Yaman Ö. The effect of varicocele on sperm morphology and DNA maturity: does acridine orange staining facilitate diagnosis? Turk J Urol 2013;39:165–169.
Oleszczuk K, Giwercman A, Bungum M. Sperm chromatin structure assay in prediction of in vitro fertilization outcome. Andrology 2016;4:290–296.
Xue LT, Wang RX, He B, Mo WY, Huang L, Wang SK, et al. Effect of sperm DNA fragmentation on clinical outcomes for Chinese couples undergoing in vitro fertilization or intracytoplasmic sperm injection. J Int Med Res 2016;44:1283–1291.
Pregl Breznik B, Kovačič B, Vlaisavljević V. Are sperm DNA fragmentation, hyperactivation, and hyaluronan-binding ability predictive for fertilization and embryo development in in vitro fertilization and intracytoplasmic sperm injection? Fertil Steril 2013;99:1233–1241.
Simon L, Castillo J, Oliva R, Lewis SE. Relationships between human sperm protamines, DNA damage and assisted reproduction outcomes. Reprod Biomed Online 2011;23:724–734.
Thomson LK, Zieschang JA, Clark AM. Oxidative deoxyribonucleic acid damage in sperm has a negative impact on clinical pregnancy rate in intrauterine insemination but not intracytoplasmic sperm injection cycles. Fertil Steril 2011;96:843–847.
Simon L, Brunborg G, Stevenson M, Lutton D, McManus J, Lewis SE. Clinical significance of sperm DNA damage in assisted reproduction outcome. Hum Reprod 2010;25:1594–1608.
Speyer BE, Pizzey AR, Ranieri M, Joshi R, Delhanty JD, Serhal P. Fall in implantation rates following ICSI with sperm with high DNA fragmentation. Hum Reprod 2010;25:1609–1618.
Tarozzi N, Nadalini M, Stronati A, Bizzaro D, Dal Prato L, Coticchio G, et al. Anomalies in sperm chromatin packaging: implications for assisted reproduction techniques. Reprod Biomed Online 2009;18:486–495.
Lin MH, Kuo-Kuang Lee R, Li SH, Lu CH, Sun FJ, Hwu YM. Sperm chromatin structure assay parameters are not related to fertilization rates, embryo quality, and pregnancy rates in in vitro fertilization and intracytoplasmic sperm injection, but might be related to spontaneous abortion rates. Fertil Steril 2008;90:352–359.
Velez de la Calle JF, Muller A, Walschaerts M, Clavere JL, Jimenez C, Wittemer C, et al. Sperm deoxyribonucleic acid fragmentation as assessed by the sperm chromatin dispersion test in assisted reproductive technology programs: results of a large prospective multicenter study. Fertil Steril 2008;90:1792–1799.
Frydman N, Prisant N, Hesters L, Frydman R, Tachdjian G, Cohen-Bacrie P, et al. Adequate ovarian follicular status does not prevent the decrease in pregnancy rates associated with high sperm DNA fragmentation. Fertil Steril 2008;89:92–97.
Benchaib M, Lornage J, Mazoyer C, Lejeune H, Salle B, François Guerin J. Sperm deoxyribonucleic acid fragmentation as a prognostic indicator of assisted reproductive technology outcome. Fertil Steril 2007;87:93–100.
Borini A, Tarozzi N, Bizzaro D, Bonu MA, Fava L, Flamigni C, et al. Sperm DNA fragmentation: paternal effect on early post-implantation embryo development in ART. Hum Reprod 2006;21:2876–2881.
Bungum M, Humaidan P, Axmon A, Spano M, Bungum L, Erenpreiss J, et al. Sperm DNA integrity assessment in prediction of assisted reproduction technology outcome. Hum Reprod 2007;22:174–179.
Henkel R, Hajimohammad M, Stalf T, Hoogendijk C, Mehnert C, Menkveld R, et al. Influence of deoxyribonucleic acid damage on fertilization and pregnancy. Fertil Steril 2004;81:965–972.
Henkel R, Kierspel E, Hajimohammad M, Stalf T, Hoogendijk C, Mehnert C, et al. DNA fragmentation of spermatozoa and assisted reproduction technology. Reprod Biomed Online 2003;7:477–484.
Benchaib M, Braun V, Lornage J, Hadj S, Salle B, Lejeune H, et al. Sperm DNA fragmentation decreases the pregnancy rate in an assisted reproductive technique. Hum Reprod 2003;18:1023–1028.
Larson-Cook KL, Brannian JD, Hansen KA, Kasperson KM, Aamold ET, Evenson DP. Relationship between the outcomes of assisted reproductive techniques and sperm DNA fragmentation as measured by the sperm chromatin structure assay. Fertil Steril 2003;80:895–902.
Duran EH, Morshedi M, Taylor S, Oehninger S. Sperm DNA quality predicts intrauterine insemination outcome: a prospective cohort study. Hum Reprod 2002;17:3122–3128.
Høst E, Lindenberg S, Smidt-Jensen S. The role of DNA strand breaks in human spermatozoa used for IVF and ICSI. Acta Obstet Gynecol Scand 2000;79:559–563.
Alvarez Sedó C, Bilinski M, Lorenzi D, Uriondo Hl, Noblía F, Longobucco V, et al. Effect of sperm DNA fragmentation on embryo development: clinical and biological aspects. JBRA Assist Reprod 2017;21:343–350.
Wdowiak A, Bakalczuk S, Bakalczuk G. The effect of sperm DNA fragmentation on the dynamics of the embryonic development in intracytoplasmatic sperm injection. Reprod Biol 2015;15:94–100.
Simon L, Murphy K, Shamsi MB, Liu L, Emery B, Aston KI, et al. Paternal influence of sperm DNA integrity on early embryonic development. Hum Reprod 2014;29:2402–2412.
Meseguer M, Santiso R, Garrido N, García-Herrero S, Remohí J, Fernandez JL. Effect of sperm DNA fragmentation on pregnancy outcome depends on oocyte quality. Fertil Steril 2011;95:124–128.
Filatov MV, Semenova EV, Vorob'eva OA, Leont'eva OA, Drobchenko EA. Relationship between abnormal sperm chromatin packing and IVF results. Mol Hum Reprod 1999;5:825–830.
Elshal MF, El-Sayed IH, Elsaied MA, El-Masry SA, Kumosani TA. Sperm head defects and disturbances in spermatozoal chromatin and DNA integrities in idiopathic infertile subjects: association with cigarette smoking. Clin Biochem 2009;42:589–594.
Belloc S, Benkhalifa M, Cohen-Bacrie M, Dalleac A, Amar E, Zini A. Sperm deoxyribonucleic acid damage in normozoospermic men is related to age and sperm progressive motility. Fertil Steril 2014;101:1588–1593.
Avendaño C, Franchi A, Duran H, Oehninger S. DNA fragmentation of normal spermatozoa negatively impacts embryo quality and intracytoplasmic sperm injection outcome. Fertil Steril 2010;94:549–557.
Boeri L, Capogrosso P, Ventimiglia E, Pederzoli F, Cazzaniga W, Chierigo F, et al. Heavy cigarette smoking and alcohol consumption are associated with impaired sperm parameters in primary infertile men. Asian J Androl 2019;21:478–485.
Taha EA, Ez-Aldin AM, Sayed SK, Ghandour NM, Mostafa T. Effect of smoking on sperm vitality, DNA integrity, seminal oxidative stress, zinc in fertile men. Urology 2012;80:822–825.
Chavarro JE, Toth TL, Wright DL, Meeker JD, Hauser R. Body mass index in relation to semen quality, sperm DNA integrity, and serum reproductive hormone levels among men attending an infertility clinic. Fertil Steril 2010;93:2222–2231.
Kort HI, Massey JB, Elsner CW, Mitchell-Leef D, Shapiro DB, Witt MA, et al. Impact of body mass index values on sperm quantity and quality. J Androl 2006;27:450–452.
Tawadrous GA, Aziz AA, Mostafa T. Effect of smoking status on seminal parameters and apoptotic markers in infertile men. J Urol 2011;186:1986–1990.
Kumar S, Murarka S, Mishra VV, Gautam AK. Environmental & lifestyle factors in deterioration of male reproductive health. Indian J Med Res 2014;140 Suppl(Suppl 1):S29–S35.
Lu X, Huang Y, Zhang H, Zhao J. Effect of diabetes mellitus on the quality and cytokine content of human semen. J Reprod Immunol 2017;123:1–2.
Radwan M, Jurewicz J, Merecz-Kot D, Sobala W, Radwan P, Bochenek M, et al. Sperm DNA damage-the effect of stress and everyday life factors. Int J Impot Res 2016;28:148–154.
Rybar R, Kopecka V, Prinosilova P, Markova P, Rubes J. Male obesity and age in relationship to semen parameters and sperm chromatin integrity. Andrologia 2011;43:286–291.
Zalata A, El-Samanoudy AZ, Shaalan D, El-Baiomy Y, Mostafa T. In vitro effect of cell phone radiation on motility, DNA fragmentation and clusterin gene expression in human sperm. Int J Fertil Steril 2015;9:129–136.
Avendaño C, Mata A, Sanchez Sarmiento CA, Doncel GF. Use of laptop computers connected to internet through Wi-Fi decreases human sperm motility and increases sperm DNA fragmentation. Fertil Steril 2012;97:39–45.e2.
Governini L, Guerranti C, De Leo V, Boschi L, Luddi A, Gori M, et al. Chromosomal aneuploidies and DNA fragmentation of human spermatozoa from patients exposed to perfluorinated compounds. Andrologia 2015;47:1012–1019.
Hauser R, Meeker JD, Singh NP, Silva MJ, Ryan L, Duty S, et al. DNA damage in human sperm is related to urinary levels of phthalate monoester and oxidative metabolites. Hum Reprod 2007;22:688–695.
Miranda-Contreras L, Gómez-Pérez R, Rojas G, Cruz I, Berrueta L, Salmen S, et al. Occupational exposure to organophosphate and carbamate pesticides affects sperm chromatin integrity and reproductive hormone levels among Venezuelan farm workers. J Occup Health 2013;55:195–203.
Vellani E, Colasante A, Mamazza L, Minasi MG, Greco E, Bevilacqua A. Association of state and trait anxiety to semen quality of in vitro fertilization patients: a controlled study. Fertil Steril 2013;99:1565–1572.
Vujkovic M, de Vries JH, Dohle GR, Bonsel GJ, Lindemans J, Macklon NS, et al. Associations between dietary patterns and semen quality in men undergoing IVF/ICSI treatment. Hum Reprod 2009;24:1304–1312.
Gosálvez J, González-Martínez M, López-Fernández C, Fernández JL, Sánchez-Martín P. Shorter abstinence decreases sperm deoxyribonucleic acid fragmentation in ejaculate. Fertil Steril 2011;96:1083–1086.
Shi X, Chan CPS, Waters T, Chi L, Chan DYL, Li TC. Lifestyle and demographic factors associated with human semen quality and sperm function. Syst Biol Reprod Med 2018;64:358–367.
Uppangala S, Mathai SE, Salian SR, Kumar D, Singh VJ, D'Souza F, et al. Sperm chromatin immaturity observed in short abstinence ejaculates affects DNA integrity and longevity in vitro. PLoS One 2016;11:e0152942
Kodama H, Yamaguchi R, Fukuda J, Kasai H, Tanaka T. Increased oxidative deoxyribonucleic acid damage in the spermatozoa of infertile male patients. Fertil Steril 1997;68:519–524.
Omu AE, Al-Azemi MK, Kehinde EO, Anim JT, Oriowo MA, Mathew TC. Indications of the mechanisms involved in improved sperm parameters by zinc therapy. Med Princ Pract 2008;17:108–116.
Greco E, Romano S, Iacobelli M, Ferrero S, Baroni E, Minasi MG, et al. ICSI in cases of sperm DNA damage: beneficial effect of oral antioxidant treatment. Hum Reprod 2005;20:2590–2594.
Martínez-Soto JC, Domingo JC, Cordobilla B, Nicolás M, Fernández L, Albero P, et al. Dietary supplementation with docosahexaenoic acid (DHA) improves seminal antioxidant status and decreases sperm DNA fragmentation. Syst Biol Reprod Med 2016;62:387–395.
Fraga CG, Motchnik PA, Shigenaga MK, Helbock HJ, Jacob RA, Ames BN. Ascorbic acid protects against endogenous oxidative DNA damage in human sperm. Proc Natl Acad Sci U S A 1991;88:11003–11006.
Abad C, Amengual MJ, Gosálvez J, Coward K, Hannaoui N, Benet J, et al. Effects of oral antioxidant treatment upon the dynamics of human sperm DNA fragmentation and subpopulations of sperm with highly degraded DNA. Andrologia 2013;45:211–216.
Vani K, Kurakula M, Syed R, Alharbi K. Clinical relevance of vitamin C among lead-exposed infertile men. Genet Test Mol Biomarkers 2012;16:1001–1006.
Gual-Frau J, Abad C, Amengual MJ, Hannaoui N, Checa MA, Ribas-Maynou J, et al. Oral antioxidant treatment partly improves integrity of human sperm DNA in infertile grade I varicocele patients. Hum Fertil (Camb) 2015;18:225–229.
Piomboni P, Gambera L, Serafini F, Campanella G, Morgante G, De Leo V. Sperm quality improvement after natural antioxidant treatment of asthenoteratospermic men with leukocytospermia. Asian J Androl 2008;10:201–206.
Negri L, Benaglia R, Monti E, Morenghi E, Pizzocaro A, Levi Setti PE. Effect of superoxide dismutase supplementation on sperm DNA fragmentation. Arch Ital Urol Androl 2017;89:212–218.
Ni K, Steger K, Yang H, Wang H, Hu K, Zhang T, et al. A comprehensive investigation of sperm DNA damage and oxidative stress injury in infertile patients with subclinical, normozoospermic, and astheno/oligozoospermic clinical varicocoele. Andrology 2016;4:816–824.
Lacerda JI, Del Giudice PT, da Silva BF, Nichi M, Fariello RM, Fraietta R, et al. Adolescent varicocele: improved sperm function after varicocelectomy. Fertil Steril 2011;95:994–999.
Afsin M, Otludil B, Dede O, Akkus M. An examination on composition of spermatozoa obtained from pre-operative and post-operative varicocele patients. Reprod Biol 2018;18:361–367.
Zini A, Azhar R, Baazeem A, Gabriel MS. Effect of microsurgical varicocelectomy on human sperm chromatin and DNA integrity: a prospective trial. Int J Androl 2011;34:14–19.
Zini A, Blumenfeld A, Libman J, Willis J. Beneficial effect of microsurgical varicocelectomy on human sperm DNA integrity. Hum Reprod 2005;20:1018–1021.
Alhathal N, San Gabriel M, Zini A. Beneficial effects of microsurgical varicocoelectomy on sperm maturation, DNA fragmentation, and nuclear sulfhydryl groups: a prospective trial. Andrology 2016;4:1204–1208.
Ghazi S, Abdelfattah H. Effect of microsurgical varicocelectomy on sperm DNA fragmentation in infertile men. Middle East Fertil Soc J 2011;16:149–153.
Zaazaa A, Adel A, Fahmy I, Elkhiat Y, Awaad AA, Mostafa T. Effect of varicocelectomy and/or mast cells stabilizer on sperm DNA fragmentation in infertile patients with varicocele. Andrology 2018;6:146–150.
La Vignera S, Condorelli R, Vicari E, D'Agata R, Calogero AE. Effects of varicocelectomy on sperm DNA fragmentation, mitochondrial function, chromatin condensation, and apoptosis. J Androl 2012;33:389–396.
Kadioglu TC, Aliyev E, Celtik M. Microscopic varicocelectomy significantly decreases the sperm DNA fragmentation index in patients with infertility. Biomed Res Int 2014;2014:695713
Lara-Cerrillo S, Gual-Frau J, Benet J, Abad C, Prats J, Amengual MJ, et al. Microsurgical varicocelectomy effect on sperm telomere length, DNA fragmentation and seminal parameters. Hum Fertil (Camb). 2020 [doi: 10.1080/14647273.2019.1711204]
García-Peiró A, Ribas-Maynou J, Oliver-Bonet M, Navarro J, Checa MA, Nikolaou A, et al. Multiple determinations of sperm DNA fragmentation show that varicocelectomy is not indicated for infertile patients with subclinical varicocele. Biomed Res Int 2014;2014:181396
Cho CL, Esteves SC, Agarwal A. Novel insights into the pathophysiology of varicocele and its association with reactive oxygen species and sperm DNA fragmentation. Asian J Androl 2016;18:186–193.
Tahamtan S, Tavalaee M, Izadi T, Barikrow N, Zakeri Z, Lockshin RA, et al. Reduced sperm telomere length in individuals with varicocele is associated with reduced genomic integrity. Sci Rep 2019;9:4336
Li F, Yamaguchi K, Okada K, Matsushita K, Ando M, Chiba K, et al. Significant improvement of sperm DNA quality after microsurgical repair of varicocele. Syst Biol Reprod Med 2012;58:274–277.
Sakamoto Y, Ishikawa T, Kondo Y, Yamaguchi K, Fujisawa M. The assessment of oxidative stress in infertile patients with varicocele. BJU Int 2008;101:1547–1552.
Abdelbaki SA, Sabry JH, Al-Adl AM, Sabry HH. The impact of coexisting sperm DNA fragmentation and seminal oxidative stress on the outcome of varicocelectomy in infertile patients: a prospective controlled study. Arab J Urol 2017;15:131–139.
Telli O, Sarici H, Kabar M, Ozgur BC, Resorlu B, Bozkurt S. Does varicocelectomy affect DNA fragmentation in infertile patients? Indian J Urol 2015;31:116–119.
Smit M, Wissenburg OG, Romijn JC, Dohle GR. Increased sperm DNA fragmentation in patients with vasectomy reversal has no prognostic value for pregnancy rate. J Urol 2010;183:662–665.
Sun XL, Wang JL, Peng YP, Gao QQ, Song T, Yu W, et al. Bilateral is superior to unilateral varicocelectomy in infertile males with left clinical and right subclinical varicocele: a prospective randomized controlled study. Int Urol Nephrol 2018;50:205–210.
Hammoud I, Boitrelle F, Ferfouri F, Vialard F, Bergere M, Wainer B, et al. Selection of normal spermatozoa with a vacuole-free head (x6300) improves selection of spermatozoa with intact DNA in patients with high sperm DNA fragmentation rates. Andrologia 2013;45:163–170.
Maettner R, Sterzik K, Isachenko V, Strehler E, Rahimi G, Alabart JL, et al. Quality of human spermatozoa: relationship between high-magnification sperm morphology and DNA integrity. Andrologia 2014;46:547–555.
Parmegiani L, Cognigni GE, Ciampaglia W, Pocognoli P, Marchi F, Filicori M. Efficiency of hyaluronic acid (HA) sperm selection. J Assist Reprod Genet 2010;27:13–16.
Pabuccu EG, Caglar GS, Tangal S, Haliloglu AH, Pabuccu R. Testicular versus ejaculated spermatozoa in ICSI cycles of normozoospermic men with high sperm DNA fragmentation and previous ART failures. Andrologia. 2017 [doi: 10.1111/and.12609]
Esteves SC, Sánchez-Martín F, Sánchez-Martín P, Schneider DT, Gosálvez J. Comparison of reproductive outcome in oligozoospermic men with high sperm DNA fragmentation undergoing intracytoplasmic sperm injection with ejaculated and testicular sperm. Fertil Steril 2015;104:1398–1405.
Mayorga-Torres BJM, Camargo M, Cadavid ÁP, du Plessis SS, Cardona Maya WD. Are oxidative stress markers associated with unexplained male infertility? Andrologia. 2017 [doi: 10.1111/and.12659]
Esquerré-Lamare C, Walschaerts M, Chansel Debordeaux L, Moreau J, Bretelle F, Isus F, et al. Sperm aneuploidy and DNA fragmentation in unexplained recurrent pregnancy loss: a multicenter case-control study. Basic Clin Androl 2018;28:4
Coughlan C, Clarke H, Cutting R, Saxton J, Waite S, Ledger W, et al. Sperm DNA fragmentation, recurrent implantation failure and recurrent miscarriage. Asian J Androl 2015;17:681–685.
Bronet F, Martínez E, Gaytán M, Liñán A, Cernuda D, Ariza M, et al. Sperm DNA fragmentation index does not correlate with the sperm or embryo aneuploidy rate in recurrent miscarriage or implantation failure patients. Hum Reprod 2012;27:1922–1929.
Gil-Villa AM, Cardona-Maya W, Agarwal A, Sharma R, Cadavid A. Assessment of sperm factors possibly involved in early recurrent pregnancy loss. Fertil Steril 2010;94:1465–1472.
Al Omrani B, Al Eisa N, Javed M, Al Ghedan M, Al Matrafi H, Al Sufyan H. Associations of sperm DNA fragmentation with lifestyle factors and semen parameters of Saudi men and its impact on ICSI outcome. Reprod Biol Endocrinol 2018;16:49
Daris B, Goropevsek A, Hojnik N, Vlaisavljević V. Sperm morphological abnormalities as indicators of DNA fragmentation and fertilization in ICSI. Arch Gynecol Obstet 2010;281:363–367.
Tavalaee M, Razavi S, Nasr-Esfahani MH. Influence of sperm chromatin anomalies on assisted reproductive technology outcome. Fertil Steril 2009;91:1119–1126.
Caglar GS, Köster F, Schöpper B, Asimakopoulos B, Nehls B, Nikolettos N, et al. Semen DNA fragmentation index, evaluated with both TUNEL and Comet assay, and the ICSI outcome. In Vivo 2007;21:1075–1080.
Muriel L, Meseguer M, Fernández JL, Alvarez J, Remohí J, Pellicer A, et al. Value of the sperm chromatin dispersion test in predicting pregnancy outcome in intrauterine insemination: a blind prospective study. Hum Reprod 2006;21:738–744.
Check JH, Graziano V, Cohen R, Krotec J, Check ML. Effect of an abnormal sperm chromatin structural assay (SCSA) on pregnancy outcome following (IVF) with ICSI in previous IVF failures. Arch Androl 2005;51:121–124.
Zini A, Meriano J, Kader K, Jarvi K, Laskin CA, Cadesky K. Potential adverse effect of sperm DNA damage on embryo quality after ICSI. Hum Reprod 2005;20:3476–3480.
Chohan KR, Griffin JT, Lafromboise M, De Jonge CJ, Carrell DT. Sperm DNA damage relationship with embryo quality and pregnancy outcome in IVF patients. Fertil Steril 2004;82 Suppl 2:S55–S56.
Seli E, Gardner DK, Schoolcraft WB, Moffatt O, Sakkas D. Extent of nuclear DNA damage in ejaculated spermatozoa impacts on blastocyst development after in vitro fertilization. Fertil Steril 2004;82:378–383.
Virro MR, Larson-Cook KL, Evenson DP. Sperm chromatin structure assay (SCSA) parameters are related to fertilization, blastocyst development, and ongoing pregnancy in in vitro fertilization and intracytoplasmic sperm injection cycles. Fertil Steril 2004;81:1289–1295.
Gandini L, Lombardo F, Paoli D, Caruso F, Eleuteri P, Leter G, et al. Full-term pregnancies achieved with ICSI despite high levels of sperm chromatin damage. Hum Reprod 2004;19:1409–1417.
Morris ID, Ilott S, Dixon L, Brison DR. The spectrum of DNA damage in human sperm assessed by single cell gel electrophoresis (Comet assay) and its relationship to fertilization and embryo development. Hum Reprod 2002;17:990–998.
Hammadeh ME, al-Hasani S, Stieber M, Rosenbaum P, Küpker D, Diedrich K, et al. The effect of chromatin condensation (aniline blue staining) and morphology (strict criteria) of human spermatozoa on fertilization, cleavage and pregnancy rates in an intracytoplasmic sperm injection programme. Hum Reprod 1996;11:2468–2471.
Esbert M, Pacheco A, Soares SR, Amorós D, Florensa M, Ballesteros A, et al. High sperm DNA fragmentation delays human embryo kinetics when oocytes from young and healthy donors are microinjected. Andrology 2018;6:697–706.
Gat I, Li N, Yasovich N, Antes R, Kuznyetsov V, Zohni K, et al. Sperm DNA fragmentation index does not correlate with blastocyst euploidy rate in egg donor cycles. Gynecol Endocrinol 2018;34:212–216.
Sun TC, Zhang Y, Li HT, Liu XM, Yi DX, Tian L, et al. Sperm DNA fragmentation index, as measured by sperm chromatin dispersion, might not predict assisted reproductive outcome. Taiwan J Obstet Gynecol 2018;57:493–498.
Gat I, Tang K, Quach K, Kuznyetsov V, Antes R, Filice M, et al. Sperm DNA fragmentation index does not correlate with blastocyst aneuploidy or morphological grading. PLoS One 2017;12:e0179002
Esbert M, Pacheco A, Vidal F, Florensa M, Riqueros M, Ballesteros A, et al. Impact of sperm DNA fragmentation on the outcome of IVF with own or donated oocytes. Reprod Biomed Online 2011;23:704–710.
Bandel I, Bungum M, Richtoff J, Malm J, Axelsson J, Pedersen HS, et al. No association between body mass index and sperm DNA integrity. Hum Reprod 2015;30:1704–1713.
Bojar I, Witczak M, Wdowiak A. Biological and environmental conditionings for a sperm DNA fragmentation. Ann Agric Environ Med 2013;20:865–868.
Goldhaber-Fiebert JD, Brandeau ML. Evaluating cost-effectiveness of interventions that affect fertility and childbearing: how health effects are measured matters. Med Decis Making 2015;35:818–846.